-- MySQL dump 10.13  Distrib 8.0.25, for macos11.3 (x86_64)
--
-- Host: 127.0.0.1    Database: gene_info
-- ------------------------------------------------------
-- Server version	8.0.25

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!50503 SET NAMES utf8mb4 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;
create database if not exists gene_info;
use gene_info;
--
-- Table structure for table `gene`
--

DROP TABLE IF EXISTS `gene`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `gene` (
  `NCBI_gene_id` varchar(45) NOT NULL,
  `Gene_symbol` varchar(45) NOT NULL,
  PRIMARY KEY (`NCBI_gene_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `gene`
--

LOCK TABLES `gene` WRITE;
/*!40000 ALTER TABLE `gene` DISABLE KEYS */;
INSERT INTO `gene` VALUES ('105787','Prkaa1'),('108079','Prkaa2'),('11622','Ahr'),('116870','Mta1'),('11846','Arg1'),('11863','Arnt'),('11910','Atf3'),('11925','Neurog3'),('12053','Bcl6'),('12151','Bmi1'),('12224','Klf5'),('12387','Ctnnb1'),('12524','Cd86'),('12590','Cdx1'),('12591','Cdx2'),('12737','Cldn1'),('12753','Clock'),('12842','Col1a1'),('12895','Cpt1b'),('12912','Creb1'),('12916','Crem'),('13122','Cyp7a1'),('13170','Dbp'),('13555','E2f1'),('13557','E2f3'),('13653','Egr1'),('13982','Esr1'),('14056','Ezh2'),('14102','Fas'),('14170','Fgf15'),('14186','Fgfr4'),('14235','Foxm1'),('14247','Fli1'),('14268','Fn1'),('14281','Fos'),('1432','MAPK14'),('14463','Gata4'),('14489','Mtpn'),('14526','Gcg'),('14581','Gfi1'),('14632','Gli1'),('14810','Grin1'),('14815','Nr3c1'),('15184','Hdac5'),('15213','Hey1'),('15248','Hic1'),('15357','Hmgcr'),('15375','Foxa1'),('15379','Onecut1'),('15930','Ido1'),('16153','Il10'),('16160','Il12b'),('16163','Il13'),('16176','Il1b'),('16189','Il4'),('16193','Il6'),('16598','Klf2'),('16842','Lef1'),('17095','Lyl1'),('17126','Smad2'),('17127','Smad3'),('17128','Smad4'),('17344','Pias2'),('17428','Mnt'),('17865','Mybl2'),('17869','Myc'),('18024','Nfe2l2'),('18033','Nfkb1'),('18044','Nfya'),('18126','Nos2'),('18128','Notch1'),('18260','Ocln'),('18609','Pdx1'),('18667','Pgr'),('19013','Ppara'),('19016','Pparg'),('19017','Ppargc1a'),('19261','Sirpa'),('1956','EGFR'),('19645','Rb1'),('19650','Rbl1'),('19698','Relb'),('19821','Rnf2'),('20186','Nr1h4'),('20296','Ccl2'),('20371','Foxp3'),('20466','Sin3a'),('20655','Sod1'),('20666','Sox11'),('20787','Srebf1'),('20788','Srebf2'),('20846','Stat1'),('20848','Stat3'),('20849','Stat4'),('21405','Hnf1a'),('21410','Hnf1b'),('21413','Tcf4'),('21417','Zeb1'),('21420','Tfap2c'),('21423','Tcf3'),('21652','Phf1'),('21781','Tfdp1'),('21803','Tgfb1'),('21872','Tjp1'),('21926','Tnf'),('21939','Cd40'),('22057','Tob1'),('22059','Trp53'),('22061','Trp63'),('22062','Trp73'),('22346','Vhl'),('22632','Yy1'),('22642','Zbtb17'),('227394','Slco4c1'),('228980','Taf4'),('230233','Elp1'),('233079','Ffar2'),('233080','Ffar3'),('2353','FOS'),('23872','Ets2'),('24088','Tlr2'),('24136','Zeb2'),('242705','E2f2'),('243764','Chrm2'),('26992','Brd7'),('2740','GLP1R'),('29560','Hif1a'),('30939','Pttg1'),('328572','Ep300'),('3458','IFNG'),('3576','CXCL8'),('3579','CXCR2'),('3586','IL10'),('3592','IL12A'),('3593','IL12B'),('3605','IL17A'),('3725','JUN'),('433759','Hdac1'),('4790','NFKB1'),('50506','DUOX2'),('50616','IL22'),('50754','Fbxw7'),('50943','FOXP3'),('54139','Irf6'),('54601','Foxo4'),('5594','MAPK1'),('5595','MAPK3'),('56458','Foxo1'),('56711','Plag1'),('57875','Angptl4'),('581','BAX'),('58205','Pdcd1lg2'),('596','BCL2'),('6348','CCL3'),('6364','CCL20'),('6372','CXCL6'),('66830','Nacc1'),('67154','Mtdh'),('7040','TGFB1'),('7097','TLR2'),('7124','TNF'),('728','C5AR1'),('80885','Hcar2'),('836','CASP3'),('8841','HDAC3'),('9971','NR1H4');
/*!40000 ALTER TABLE `gene` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `gene_kegg_info`
--

DROP TABLE IF EXISTS `gene_kegg_info`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `gene_kegg_info` (
  `Gene_kegg_index` int NOT NULL AUTO_INCREMENT,
  `Gene_symbol` longtext,
  `Gene_kegg_pathway` longtext,
  `Gene_Kegg_brite` longtext,
  PRIMARY KEY (`Gene_kegg_index`)
) ENGINE=InnoDB AUTO_INCREMENT=167 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `gene_kegg_info`
--

LOCK TABLES `gene_kegg_info` WRITE;
/*!40000 ALTER TABLE `gene_kegg_info` DISABLE KEYS */;
INSERT INTO `gene_kegg_info` VALUES (1,'Ahr','[Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=Ahr), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=Ahr), Chemical carcinogenesis - reactive oxygen species(https://www.kegg.jp/pathway/map=map05208&keyword=Ahr), Geraniol degradation(https://www.kegg.jp/pathway/map=map00281&keyword=Ahr), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Ahr), Glycolysis / Gluconeogenesis(https://www.kegg.jp/pathway/map=map00010&keyword=Ahr), Pyruvate metabolism(https://www.kegg.jp/pathway/map=map00620&keyword=Ahr), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Ahr), Biosynthesis of secondary metabolites(https://www.kegg.jp/pathway/map=map01110&keyword=Ahr), Microbial metabolism in diverse environments(https://www.kegg.jp/pathway/map=map01120&keyword=Ahr)]','04659 Th17 cell differentiation; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 04934 Cushing syndrome; 03000 Transcription factors [BR:mmu03000]; Factors with PAS domain; '),(2,'Angptl4','[PPAR signaling pathway(https://www.kegg.jp/pathway/map=map03320&keyword=Angptl4), Cholesterol metabolism(https://www.kegg.jp/pathway/map=map04979&keyword=Angptl4)]','03320 PPAR signaling pathway; 04979 Cholesterol metabolism; 04147 Exosome [BR:mmu04147]; Exosomal proteins of breast milk; '),(3,'Arg1','[]','00220 Arginine biosynthesis; 00330 Arginine and proline metabolism; 05146 Amoebiasis; 3.5.3.1  arginase; '),(4,'Arnt','[Renal cell carcinoma(https://www.kegg.jp/pathway/map=map05211&keyword=Arnt), Lipopolysaccharide biosynthesis(https://www.kegg.jp/pathway/map=map00540&keyword=Arnt), Cationic antimicrobial peptide (CAMP) resistance(https://www.kegg.jp/pathway/map=map01503&keyword=Arnt), Circadian rhythm(https://www.kegg.jp/pathway/map=map04710&keyword=Arnt), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Arnt), Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=Arnt), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Arnt), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=Arnt), HIF-1 signaling pathway(https://www.kegg.jp/pathway/map=map04066&keyword=Arnt), Circadian rhythm - fly(https://www.kegg.jp/pathway/map=map04711&keyword=Arnt), Dopaminergic synapse(https://www.kegg.jp/pathway/map=map04728&keyword=Arnt), Chemical carcinogenesis - reactive oxygen species(https://www.kegg.jp/pathway/map=map05208&keyword=Arnt)]','04066 HIF-1 signaling pathway; 05200 Pathways in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05211 Renal cell carcinoma; 04934 Cushing syndrome; 03000 Transcription factors [BR:mmu03000]; Factors with PAS domain; '),(5,'Atf3','[]','03000 Transcription factors [BR:mmu03000]; AP-1(-like) components, Fos; AP-1(-like) components, CRE-BP/ATF; '),(6,'BAX','[Colorectal cancer(https://www.kegg.jp/pathway/map=map05210&keyword=BAX), Platinum drug resistance(https://www.kegg.jp/pathway/map=map01524&keyword=BAX), Apoptosis(https://www.kegg.jp/pathway/map=map04210&keyword=BAX), Sphingolipid signaling pathway(https://www.kegg.jp/pathway/map=map04071&keyword=BAX), Pathways of neurodegeneration - multiple diseases(https://www.kegg.jp/pathway/map=map05022&keyword=BAX), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=BAX), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=BAX), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=BAX), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=BAX), Endometrial cancer(https://www.kegg.jp/pathway/map=map05213&keyword=BAX), Small cell lung cancer(https://www.kegg.jp/pathway/map=map05222&keyword=BAX), Gastric cancer(https://www.kegg.jp/pathway/map=map05226&keyword=BAX), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=BAX), Prion disease(https://www.kegg.jp/pathway/map=map05020&keyword=BAX), EGFR tyrosine kinase inhibitor resistance(https://www.kegg.jp/pathway/map=map01521&keyword=BAX), Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=BAX), p53 signaling pathway(https://www.kegg.jp/pathway/map=map04115&keyword=BAX), Protein processing in endoplasmic reticulum(https://www.kegg.jp/pathway/map=map04141&keyword=BAX), Longevity regulating pathway(https://www.kegg.jp/pathway/map=map04211&keyword=BAX), Apoptosis - multiple species(https://www.kegg.jp/pathway/map=map04215&keyword=BAX)]','04141 Protein processing in endoplasmic reticulum; 04071 Sphingolipid signaling pathway; 04210 Apoptosis; 04215 Apoptosis - multiple species; 04217 Necroptosis; 04115 p53 signaling pathway; 04722 Neurotrophin signaling pathway; 04211 Longevity regulating pathway; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05203 Viral carcinogenesis; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05216 Thyroid cancer; 05220 Chronic myeloid leukemia; 05217 Basal cell carcinoma; 05218 Melanoma; 05213 Endometrial cancer; 05224 Breast cancer; 05222 Small cell lung cancer; 05223 Non-small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05131 Shigellosis; 05152 Tuberculosis; 05012 Parkinson disease; 05014 Amyotrophic lateral sclerosis; 05016 Huntington disease; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 04932 Non-alcoholic fatty liver disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 01521 EGFR tyrosine kinase inhibitor resistance; 01524 Platinum drug resistance; 01522 Endocrine resistance; 03029 Mitochondrial biogenesis [BR:hsa03029]; 02000 Transporters [BR:hsa02000]; Fission and Fusion factors; Pores ion channels [TC:1]; '),(7,'BCL2','[EGFR tyrosine kinase inhibitor resistance(https://www.kegg.jp/pathway/map=map01521&keyword=BCL2), Apoptosis(https://www.kegg.jp/pathway/map=map04210&keyword=BCL2), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=BCL2), NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=BCL2), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=BCL2), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=BCL2), Apoptosis - multiple species(https://www.kegg.jp/pathway/map=map04215&keyword=BCL2), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=BCL2), MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=BCL2), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=BCL2), Amyotrophic lateral sclerosis(https://www.kegg.jp/pathway/map=map05014&keyword=BCL2), Pathways of neurodegeneration - multiple diseases(https://www.kegg.jp/pathway/map=map05022&keyword=BCL2), Shigellosis(https://www.kegg.jp/pathway/map=map05131&keyword=BCL2), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=BCL2), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=BCL2), Protein processing in endoplasmic reticulum(https://www.kegg.jp/pathway/map=map04141&keyword=BCL2), Hedgehog signaling pathway(https://www.kegg.jp/pathway/map=map04340&keyword=BCL2), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=BCL2), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=BCL2), p53 signaling pathway(https://www.kegg.jp/pathway/map=map04115&keyword=BCL2)]','04141 Protein processing in endoplasmic reticulum; 04340 Hedgehog signaling pathway; 04630 JAK-STAT signaling pathway; 04064 NF-kappa B signaling pathway; 04066 HIF-1 signaling pathway; 04071 Sphingolipid signaling pathway; 04151 PI3K-Akt signaling pathway; 04140 Autophagy - animal; 04210 Apoptosis; 04215 Apoptosis - multiple species; 04217 Necroptosis; 04115 p53 signaling pathway; 04510 Focal adhesion; 04621 NOD-like receptor signaling pathway; 04915 Estrogen signaling pathway; 04928 Parathyroid hormone synthesis, secretion and action; 04261 Adrenergic signaling in cardiomyocytes; 04725 Cholinergic synapse; 04722 Neurotrophin signaling pathway; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05207 Chemical carcinogenesis - receptor activation; 05210 Colorectal cancer; 05226 Gastric cancer; 05215 Prostate cancer; 05222 Small cell lung cancer; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05169 Epstein-Barr virus infection; 05132 Salmonella infection; 05131 Shigellosis; 05152 Tuberculosis; 05145 Toxoplasmosis; 05014 Amyotrophic lateral sclerosis; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 04933 AGE-RAGE signaling pathway in diabetic complications; 01521 EGFR tyrosine kinase inhibitor resistance; 01524 Platinum drug resistance; 01522 Endocrine resistance; 01009 Protein phosphatases and associated proteins [BR:hsa01009]; PP1-interacting proteins (PIPs); '),(8,'Bcl6','[FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Bcl6), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=Bcl6), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Bcl6)]','04068 FoxO signaling pathway; 05202 Transcriptional misregulation in cancer; 05207 Chemical carcinogenesis - receptor activation; 03000 Transcription factors [BR:mmu03000]; Cys2His2 BTB-ZF factors; '),(9,'Bmi1','[Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Bmi1)]','04550 Signaling pathways regulating pluripotency of stem cells; 05202 Transcriptional misregulation in cancer; 05206 MicroRNAs in cancer; 03036 Chromosome and associated proteins [BR:mmu03036]; PRC1 (polycomb repressive complex 1); '),(10,'Brd7','[Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Brd7)]','05225 Hepatocellular carcinoma; 03036 Chromosome and associated proteins [BR:mmu03036]; PBAF complex; '),(11,'C5AR1','[Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=C5AR1), Complement and coagulation cascades(https://www.kegg.jp/pathway/map=map04610&keyword=C5AR1), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=C5AR1), Neuroactive ligand-receptor interaction(https://www.kegg.jp/pathway/map=map04080&keyword=C5AR1), Neutrophil extracellular trap formation(https://www.kegg.jp/pathway/map=map04613&keyword=C5AR1), Staphylococcus aureus infection(https://www.kegg.jp/pathway/map=map05150&keyword=C5AR1)]','04080 Neuroactive ligand-receptor interaction; 04610 Complement and coagulation cascades; 04613 Neutrophil extracellular trap formation; 05171 Coronavirus disease - COVID-19; 05150 Staphylococcus aureus infection; 04936 Alcoholic liver disease; 04030 G protein-coupled receptors [BR:hsa04030]; 04090 CD molecules [BR:hsa04090]; Anaphylatoxin; Proteins; '),(12,'CASP3','[Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=CASP3), Apoptosis - multiple species(https://www.kegg.jp/pathway/map=map04215&keyword=CASP3), Alzheimer disease(https://www.kegg.jp/pathway/map=map05010&keyword=CASP3), Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=CASP3), Pathways of neurodegeneration - multiple diseases(https://www.kegg.jp/pathway/map=map05022&keyword=CASP3), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=CASP3), Colorectal cancer(https://www.kegg.jp/pathway/map=map05210&keyword=CASP3), Platinum drug resistance(https://www.kegg.jp/pathway/map=map01524&keyword=CASP3), p53 signaling pathway(https://www.kegg.jp/pathway/map=map04115&keyword=CASP3), Apoptosis(https://www.kegg.jp/pathway/map=map04210&keyword=CASP3), Natural killer cell mediated cytotoxicity(https://www.kegg.jp/pathway/map=map04650&keyword=CASP3), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=CASP3), Serotonergic synapse(https://www.kegg.jp/pathway/map=map04726&keyword=CASP3), Non-alcoholic fatty liver disease(https://www.kegg.jp/pathway/map=map04932&keyword=CASP3), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=CASP3), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=CASP3), Parkinson disease(https://www.kegg.jp/pathway/map=map05012&keyword=CASP3), Amyotrophic lateral sclerosis(https://www.kegg.jp/pathway/map=map05014&keyword=CASP3), Prion disease(https://www.kegg.jp/pathway/map=map05020&keyword=CASP3), Epithelial cell signaling in Helicobacter pylori infection(https://www.kegg.jp/pathway/map=map05120&keyword=CASP3)]','04010 MAPK signaling pathway; 04668 TNF signaling pathway; 04210 Apoptosis; 04215 Apoptosis - multiple species; 04115 p53 signaling pathway; 04650 Natural killer cell mediated cytotoxicity; 04657 IL-17 signaling pathway; 04726 Serotonergic synapse; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05205 Proteoglycans in cancer; 05203 Viral carcinogenesis; 05210 Colorectal cancer; 05222 Small cell lung cancer; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05120 Epithelial cell signaling in Helicobacter pylori infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05145 Toxoplasmosis; 05010 Alzheimer disease; 05012 Parkinson disease; 05014 Amyotrophic lateral sclerosis; 05016 Huntington disease; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 05416 Viral myocarditis; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 01524 Platinum drug resistance; 01002 Peptidases and inhibitors [BR:hsa01002]; 3.4.22.56  caspase-3; Family C14: caspase family; '),(13,'Ccl2','[Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=Ccl2), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Ccl2), Chemokine signaling pathway(https://www.kegg.jp/pathway/map=map04062&keyword=Ccl2), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=Ccl2), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=Ccl2), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=Ccl2), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=Ccl2), Herpes simplex virus 1 infection(https://www.kegg.jp/pathway/map=map05168&keyword=Ccl2), Rheumatoid arthritis(https://www.kegg.jp/pathway/map=map05323&keyword=Ccl2), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=Ccl2), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=Ccl2), C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=Ccl2), NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=Ccl2), NOD-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04621&keyword=Ccl2), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Ccl2), Yersinia infection(https://www.kegg.jp/pathway/map=map05135&keyword=Ccl2), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=Ccl2), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=Ccl2), Influenza A(https://www.kegg.jp/pathway/map=map05164&keyword=Ccl2), Fluid shear stress and atherosclerosis(https://www.kegg.jp/pathway/map=map05418&keyword=Ccl2)]','04668 TNF signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04621 NOD-like receptor signaling pathway; 04657 IL-17 signaling pathway; 04062 Chemokine signaling pathway; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05135 Yersinia infection; 05144 Malaria; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 04933 AGE-RAGE signaling pathway in diabetic complications; 04052 Cytokines and growth factors [BR:mmu04052]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Chemokines; Chemokines; '),(14,'CCL20','[Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=CCL20), Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=CCL20), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=CCL20), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=CCL20), Rheumatoid arthritis(https://www.kegg.jp/pathway/map=map05323&keyword=CCL20), Chemokine signaling pathway(https://www.kegg.jp/pathway/map=map04062&keyword=CCL20)]','04668 TNF signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04657 IL-17 signaling pathway; 04062 Chemokine signaling pathway; 05323 Rheumatoid arthritis; 04052 Cytokines and growth factors [BR:hsa04052]; Chemokines; '),(15,'CCL3','[Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=CCL3), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=CCL3), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=CCL3), Rheumatoid arthritis(https://www.kegg.jp/pathway/map=map05323&keyword=CCL3), Chemokine signaling pathway(https://www.kegg.jp/pathway/map=map04062&keyword=CCL3), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=CCL3), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=CCL3), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=CCL3), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=CCL3)]','04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04620 Toll-like receptor signaling pathway; 04062 Chemokine signaling pathway; 05163 Human cytomegalovirus infection; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05417 Lipid and atherosclerosis; 04052 Cytokines and growth factors [BR:hsa04052]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Chemokines; Chemokines; '),(16,'Cd40','[Cell adhesion molecules(https://www.kegg.jp/pathway/map=map04514&keyword=Cd40), Autoimmune thyroid disease(https://www.kegg.jp/pathway/map=map05320&keyword=Cd40), Allograft rejection(https://www.kegg.jp/pathway/map=map05330&keyword=Cd40), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Cd40), NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=Cd40), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=Cd40), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=Cd40), Asthma(https://www.kegg.jp/pathway/map=map05310&keyword=Cd40), Systemic lupus erythematosus(https://www.kegg.jp/pathway/map=map05322&keyword=Cd40), Primary immunodeficiency(https://www.kegg.jp/pathway/map=map05340&keyword=Cd40), Viral myocarditis(https://www.kegg.jp/pathway/map=map05416&keyword=Cd40), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=Cd40), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=Cd40), T cell receptor signaling pathway(https://www.kegg.jp/pathway/map=map04660&keyword=Cd40), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=Cd40), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Cd40), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=Cd40)]','04064 NF-kappa B signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04514 Cell adhesion molecules; 04620 Toll-like receptor signaling pathway; 04672 Intestinal immune network for IgA production; 05202 Transcriptional misregulation in cancer; 05166 Human T-cell leukemia virus 1 infection; 05169 Epstein-Barr virus infection; 05144 Malaria; 05145 Toxoplasmosis; 05310 Asthma; 05322 Systemic lupus erythematosus; 05320 Autoimmune thyroid disease; 05330 Allograft rejection; 05340 Primary immunodeficiency; 05417 Lipid and atherosclerosis; 05416 Viral myocarditis; 04050 Cytokine receptors [BR:mmu04050]; 04090 CD molecules [BR:mmu04090]; TNF receptor superfamily; Proteins; '),(17,'Cd86','[Cell adhesion molecules(https://www.kegg.jp/pathway/map=map04514&keyword=Cd86), Allograft rejection(https://www.kegg.jp/pathway/map=map05330&keyword=Cd86), Autoimmune thyroid disease(https://www.kegg.jp/pathway/map=map05320&keyword=Cd86), Virion - Adenovirus(https://www.kegg.jp/pathway/map=map03267&keyword=Cd86), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=Cd86), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=Cd86), Type I diabetes mellitus(https://www.kegg.jp/pathway/map=map04940&keyword=Cd86), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=Cd86), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Cd86), Systemic lupus erythematosus(https://www.kegg.jp/pathway/map=map05322&keyword=Cd86), Rheumatoid arthritis(https://www.kegg.jp/pathway/map=map05323&keyword=Cd86), Graft-versus-host disease(https://www.kegg.jp/pathway/map=map05332&keyword=Cd86), Viral myocarditis(https://www.kegg.jp/pathway/map=map05416&keyword=Cd86)]','03267 Virion - Adenovirus; 04514 Cell adhesion molecules; 04620 Toll-like receptor signaling pathway; 04672 Intestinal immune network for IgA production; 05202 Transcriptional misregulation in cancer; 05167 Kaposi sarcoma-associated herpesvirus infection; 05322 Systemic lupus erythematosus; 05323 Rheumatoid arthritis; 05320 Autoimmune thyroid disease; 05330 Allograft rejection; 05332 Graft-versus-host disease; 05416 Viral myocarditis; 04940 Type I diabetes mellitus; 04147 Exosome [BR:mmu04147]; 04090 CD molecules [BR:mmu04090]; Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell); Proteins; '),(18,'Cdx1','[]','03000 Transcription factors [BR:mmu03000]; Homeo domain ANTP: HOXL; '),(19,'Cdx2','[Gastric cancer(https://www.kegg.jp/pathway/map=map05226&keyword=Cdx2)]','05226 Gastric cancer; 03000 Transcription factors [BR:mmu03000]; Homeo domain ANTP: HOXL; '),(20,'Chrm2','[Cholinergic synapse(https://www.kegg.jp/pathway/map=map04725&keyword=Chrm2), Calcium signaling pathway(https://www.kegg.jp/pathway/map=map04020&keyword=Chrm2), cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=Chrm2), Neuroactive ligand-receptor interaction(https://www.kegg.jp/pathway/map=map04080&keyword=Chrm2), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=Chrm2), Regulation of actin cytoskeleton(https://www.kegg.jp/pathway/map=map04810&keyword=Chrm2)]','04020 Calcium signaling pathway; 04024 cAMP signaling pathway; 04151 PI3K-Akt signaling pathway; 04080 Neuroactive ligand-receptor interaction; 04810 Regulation of actin cytoskeleton; 04725 Cholinergic synapse; 04030 G protein-coupled receptors [BR:mmu04030]; Acetylcholine (muscarinic); '),(21,'Cldn1','[]','04514 Cell adhesion molecules; 04530 Tight junction; 04670 Leukocyte transendothelial migration; 05160 Hepatitis C; 03037 Cilium and associated proteins [BR:mmu03037]; 04147 Exosome [BR:mmu04147]; Stereociliary proteins; Exosomal proteins of ovarian cancer cells; Exosomal proteins of colorectal cancer cells; '),(22,'Clock','[Circadian rhythm(https://www.kegg.jp/pathway/map=map04710&keyword=Clock), Circadian rhythm - fly(https://www.kegg.jp/pathway/map=map04711&keyword=Clock), Circadian entrainment(https://www.kegg.jp/pathway/map=map04713&keyword=Clock), Circadian rhythm - plant(https://www.kegg.jp/pathway/map=map04712&keyword=Clock), Dopaminergic synapse(https://www.kegg.jp/pathway/map=map04728&keyword=Clock)]','04728 Dopaminergic synapse; 04710 Circadian rhythm; 03000 Transcription factors [BR:mmu03000]; 03036 Chromosome and associated proteins [BR:mmu03036]; 2.3.1.48  histone acetyltransferase; Factors with PAS domain; HATs (histone acetyltransferases); '),(23,'Col1a1','[]','04151 PI3K-Akt signaling pathway; 04512 ECM-receptor interaction; 04510 Focal adhesion; 04611 Platelet activation; 04926 Relaxin signaling pathway; 04974 Protein digestion and absorption; 05205 Proteoglycans in cancer; 05165 Human papillomavirus infection; 05146 Amoebiasis; 05415 Diabetic cardiomyopathy; 04933 AGE-RAGE signaling pathway in diabetic complications; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Extracellular matrix molecules; '),(24,'Cpt1b','[Fatty acid metabolism(https://www.kegg.jp/pathway/map=map01212&keyword=Cpt1b), Glucagon signaling pathway(https://www.kegg.jp/pathway/map=map04922&keyword=Cpt1b), Diabetic cardiomyopathy(https://www.kegg.jp/pathway/map=map05415&keyword=Cpt1b), Fatty acid degradation(https://www.kegg.jp/pathway/map=map00071&keyword=Cpt1b), PPAR signaling pathway(https://www.kegg.jp/pathway/map=map03320&keyword=Cpt1b), AMPK signaling pathway(https://www.kegg.jp/pathway/map=map04152&keyword=Cpt1b), Thermogenesis(https://www.kegg.jp/pathway/map=map04714&keyword=Cpt1b), Adipocytokine signaling pathway(https://www.kegg.jp/pathway/map=map04920&keyword=Cpt1b), Insulin resistance(https://www.kegg.jp/pathway/map=map04931&keyword=Cpt1b), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Cpt1b)]','00071 Fatty acid degradation; 04152 AMPK signaling pathway; 04922 Glucagon signaling pathway; 04920 Adipocytokine signaling pathway; 03320 PPAR signaling pathway; 04714 Thermogenesis; 05415 Diabetic cardiomyopathy; 04936 Alcoholic liver disease; 04931 Insulin resistance; 03029 Mitochondrial biogenesis [BR:mmu03029]; 2.3.1.21  carnitine O-palmitoyltransferase; Other regulator of mitochondrial biogenesis; '),(25,'Creb1','[Estrogen signaling pathway(https://www.kegg.jp/pathway/map=map04915&keyword=Creb1), Circadian entrainment(https://www.kegg.jp/pathway/map=map04713&keyword=Creb1), Glucagon signaling pathway(https://www.kegg.jp/pathway/map=map04922&keyword=Creb1), Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=Creb1), Amphetamine addiction(https://www.kegg.jp/pathway/map=map05031&keyword=Creb1), Alcoholism(https://www.kegg.jp/pathway/map=map05034&keyword=Creb1), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=Creb1), cGMP-PKG signaling pathway(https://www.kegg.jp/pathway/map=map04022&keyword=Creb1), cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=Creb1), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=Creb1), AMPK signaling pathway(https://www.kegg.jp/pathway/map=map04152&keyword=Creb1), Longevity regulating pathway(https://www.kegg.jp/pathway/map=map04211&keyword=Creb1), Adrenergic signaling in cardiomyocytes(https://www.kegg.jp/pathway/map=map04261&keyword=Creb1), Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=Creb1), Antigen processing and presentation(https://www.kegg.jp/pathway/map=map04612&keyword=Creb1), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=Creb1), Circadian rhythm(https://www.kegg.jp/pathway/map=map04710&keyword=Creb1), Thermogenesis(https://www.kegg.jp/pathway/map=map04714&keyword=Creb1), Cholinergic synapse(https://www.kegg.jp/pathway/map=map04725&keyword=Creb1), Dopaminergic synapse(https://www.kegg.jp/pathway/map=map04728&keyword=Creb1)]','04668 TNF signaling pathway; 04024 cAMP signaling pathway; 04022 cGMP-PKG signaling pathway; 04151 PI3K-Akt signaling pathway; 04152 AMPK signaling pathway; 04612 Antigen processing and presentation; 04911 Insulin secretion; 04922 Glucagon signaling pathway; 04915 Estrogen signaling pathway; 04926 Relaxin signaling pathway; 04935 Growth hormone synthesis, secretion and action; 04918 Thyroid hormone synthesis; 04928 Parathyroid hormone synthesis, secretion and action; 04916 Melanogenesis; 04924 Renin secretion; 04925 Aldosterone synthesis and secretion; 04927 Cortisol synthesis and secretion; 04261 Adrenergic signaling in cardiomyocytes; 04962 Vasopressin-regulated water reabsorption; 04725 Cholinergic synapse; 04728 Dopaminergic synapse; 04380 Osteoclast differentiation; 04211 Longevity regulating pathway; 04710 Circadian rhythm; 04713 Circadian entrainment; 04714 Thermogenesis; 05207 Chemical carcinogenesis - receptor activation; 05203 Viral carcinogenesis; 05215 Prostate cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05165 Human papillomavirus infection; 05152 Tuberculosis; 05016 Huntington disease; 05020 Prion disease; 05030 Cocaine addiction; 05031 Amphetamine addiction; 05034 Alcoholism; 04931 Insulin resistance; 04934 Cushing syndrome; 03000 Transcription factors [BR:mmu03000]; 03029 Mitochondrial biogenesis [BR:mmu03029]; CREB; Ubiquitas transcription factors; '),(26,'Crem','[Parathyroid hormone synthesis, secretion and action(https://www.kegg.jp/pathway/map=map04928&keyword=Crem), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Crem), Biosynthesis of secondary metabolites(https://www.kegg.jp/pathway/map=map01110&keyword=Crem), Biosynthesis of various antibiotics(https://www.kegg.jp/pathway/map=map00998&keyword=Crem), Adrenergic signaling in cardiomyocytes(https://www.kegg.jp/pathway/map=map04261&keyword=Crem)]','04261 Adrenergic signaling in cardiomyocytes; 03000 Transcription factors [BR:mmu03000]; CREB; '),(27,'Ctnnb1','[Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Ctnnb1), Adherens junction(https://www.kegg.jp/pathway/map=map04520&keyword=Ctnnb1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Ctnnb1), Proteoglycans in cancer(https://www.kegg.jp/pathway/map=map05205&keyword=Ctnnb1), Endometrial cancer(https://www.kegg.jp/pathway/map=map05213&keyword=Ctnnb1), Rap1 signaling pathway(https://www.kegg.jp/pathway/map=map04015&keyword=Ctnnb1), Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Ctnnb1), Leukocyte transendothelial migration(https://www.kegg.jp/pathway/map=map04670&keyword=Ctnnb1), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Ctnnb1), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=Ctnnb1), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=Ctnnb1), Colorectal cancer(https://www.kegg.jp/pathway/map=map05210&keyword=Ctnnb1), Gastric cancer(https://www.kegg.jp/pathway/map=map05226&keyword=Ctnnb1), Wnt signaling pathway(https://www.kegg.jp/pathway/map=map04310&keyword=Ctnnb1), Hippo signaling pathway(https://www.kegg.jp/pathway/map=map04390&keyword=Ctnnb1), Focal adhesion(https://www.kegg.jp/pathway/map=map04510&keyword=Ctnnb1), Melanogenesis(https://www.kegg.jp/pathway/map=map04916&keyword=Ctnnb1), Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=Ctnnb1), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Ctnnb1), Alzheimer disease(https://www.kegg.jp/pathway/map=map05010&keyword=Ctnnb1)]','04015 Rap1 signaling pathway; 04310 Wnt signaling pathway; 04390 Hippo signaling pathway; 04510 Focal adhesion; 04520 Adherens junction; 04550 Signaling pathways regulating pluripotency of stem cells; 04670 Leukocyte transendothelial migration; 04919 Thyroid hormone signaling pathway; 04916 Melanogenesis; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05210 Colorectal cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05216 Thyroid cancer; 05217 Basal cell carcinoma; 05215 Prostate cancer; 05213 Endometrial cancer; 05224 Breast cancer; 05160 Hepatitis C; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05165 Human papillomavirus infection; 05132 Salmonella infection; 05100 Bacterial invasion of epithelial cells; 05010 Alzheimer disease; 05022 Pathways of neurodegeneration - multiple diseases; 05418 Fluid shear stress and atherosclerosis; 05412 Arrhythmogenic right ventricular cardiomyopathy; 04936 Alcoholic liver disease; 04934 Cushing syndrome; '),(28,'CXCL6','[Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=CXCL6), Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=CXCL6)]','04668 TNF signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04657 IL-17 signaling pathway; 04062 Chemokine signaling pathway; 05133 Pertussis; 05323 Rheumatoid arthritis; 04052 Cytokines and growth factors [BR:hsa04052]; Chemokines; '),(29,'CXCL8','[Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=CXCL8), Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=CXCL8), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=CXCL8)]','04064 NF-kappa B signaling pathway; 04072 Phospholipase D signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04218 Cellular senescence; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04657 IL-17 signaling pathway; 04062 Chemokine signaling pathway; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05219 Bladder cancer; 05161 Hepatitis B; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05120 Epithelial cell signaling in Helicobacter pylori infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05131 Shigellosis; 05135 Yersinia infection; 05133 Pertussis; 05134 Legionellosis; 05146 Amoebiasis; 05144 Malaria; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05417 Lipid and atherosclerosis; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 04052 Cytokines and growth factors [BR:hsa04052]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Chemokines; Chemokines; '),(30,'CXCR2','[Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=CXCR2), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=CXCR2), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=CXCR2), Chemokine signaling pathway(https://www.kegg.jp/pathway/map=map04062&keyword=CXCR2), Phospholipase D signaling pathway(https://www.kegg.jp/pathway/map=map04072&keyword=CXCR2), Endocytosis(https://www.kegg.jp/pathway/map=map04144&keyword=CXCR2), Epithelial cell signaling in Helicobacter pylori infection(https://www.kegg.jp/pathway/map=map05120&keyword=CXCR2)]','04072 Phospholipase D signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04144 Endocytosis; 04062 Chemokine signaling pathway; 05163 Human cytomegalovirus infection; 05120 Epithelial cell signaling in Helicobacter pylori infection; 04030 G protein-coupled receptors [BR:hsa04030]; 04050 Cytokine receptors [BR:hsa04050]; 04090 CD molecules [BR:hsa04090]; CXC Chemokine; CXC Chemokine; Proteins; '),(31,'Cyp7a1','[Primary bile acid biosynthesis(https://www.kegg.jp/pathway/map=map00120&keyword=Cyp7a1), PPAR signaling pathway(https://www.kegg.jp/pathway/map=map03320&keyword=Cyp7a1), Bile secretion(https://www.kegg.jp/pathway/map=map04976&keyword=Cyp7a1), Cholesterol metabolism(https://www.kegg.jp/pathway/map=map04979&keyword=Cyp7a1), Steroid hormone biosynthesis(https://www.kegg.jp/pathway/map=map00140&keyword=Cyp7a1), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Cyp7a1)]','00120 Primary bile acid biosynthesis; 00140 Steroid hormone biosynthesis; 03320 PPAR signaling pathway; 04976 Bile secretion; 04979 Cholesterol metabolism; 00199 Cytochrome P450 [BR:mmu00199]; 1.14.14.23  cholesterol 7alpha-monooxygenase; CYP7 family; '),(32,'Dbp','[Amyotrophic lateral sclerosis(https://www.kegg.jp/pathway/map=map05014&keyword=Dbp), Pathways of neurodegeneration - multiple diseases(https://www.kegg.jp/pathway/map=map05022&keyword=Dbp), Circadian rhythm(https://www.kegg.jp/pathway/map=map04710&keyword=Dbp), mRNA surveillance pathway(https://www.kegg.jp/pathway/map=map03015&keyword=Dbp), Viral life cycle - HIV-1(https://www.kegg.jp/pathway/map=map03250&keyword=Dbp), Peroxisome(https://www.kegg.jp/pathway/map=map04146&keyword=Dbp), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=Dbp)]','04710 Circadian rhythm; 03000 Transcription factors [BR:mmu03000]; bZIP/PAR; '),(33,'DUOX2','[Thyroid hormone synthesis(https://www.kegg.jp/pathway/map=map04918&keyword=DUOX2)]','04918 Thyroid hormone synthesis; 04131 Membrane trafficking [BR:hsa04131]; 1.6.3.1  NAD(P)H oxidase (H2O2-forming); 1.11.1.-; NADPH oxidases; '),(34,'E2f1','[MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=E2f1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=E2f1), Glioma(https://www.kegg.jp/pathway/map=map05214&keyword=E2f1), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=E2f1), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=E2f1), Mitophagy - animal(https://www.kegg.jp/pathway/map=map04137&keyword=E2f1), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=E2f1), Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=E2f1), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=E2f1), Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=E2f1), Hepatitis C(https://www.kegg.jp/pathway/map=map05160&keyword=E2f1), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=E2f1), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=E2f1), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=E2f1), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=E2f1), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=E2f1), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=E2f1), Pancreatic cancer(https://www.kegg.jp/pathway/map=map05212&keyword=E2f1), Prostate cancer(https://www.kegg.jp/pathway/map=map05215&keyword=E2f1), Melanoma(https://www.kegg.jp/pathway/map=map05218&keyword=E2f1)]','04137 Mitophagy - animal; 04110 Cell cycle; 04218 Cellular senescence; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05207 Chemical carcinogenesis - receptor activation; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05220 Chronic myeloid leukemia; 05218 Melanoma; 05219 Bladder cancer; 05215 Prostate cancer; 05224 Breast cancer; 05222 Small cell lung cancer; 05223 Non-small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 04934 Cushing syndrome; 01522 Endocrine resistance; 03000 Transcription factors [BR:mmu03000]; Fork head/winged helix cell cycle-controlling factors, E2F; '),(35,'E2f2','[Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=E2f2), Glioma(https://www.kegg.jp/pathway/map=map05214&keyword=E2f2), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=E2f2), MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=E2f2), Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=E2f2), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=E2f2), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=E2f2), Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=E2f2), Hepatitis C(https://www.kegg.jp/pathway/map=map05160&keyword=E2f2), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=E2f2), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=E2f2), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=E2f2), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=E2f2), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=E2f2), Pancreatic cancer(https://www.kegg.jp/pathway/map=map05212&keyword=E2f2), Prostate cancer(https://www.kegg.jp/pathway/map=map05215&keyword=E2f2), Melanoma(https://www.kegg.jp/pathway/map=map05218&keyword=E2f2), Bladder cancer(https://www.kegg.jp/pathway/map=map05219&keyword=E2f2), Chronic myeloid leukemia(https://www.kegg.jp/pathway/map=map05220&keyword=E2f2), Small cell lung cancer(https://www.kegg.jp/pathway/map=map05222&keyword=E2f2)]','04110 Cell cycle; 04218 Cellular senescence; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05220 Chronic myeloid leukemia; 05218 Melanoma; 05219 Bladder cancer; 05215 Prostate cancer; 05224 Breast cancer; 05222 Small cell lung cancer; 05223 Non-small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 04934 Cushing syndrome; 01522 Endocrine resistance; 03000 Transcription factors [BR:mmu03000]; Fork head/winged helix cell cycle-controlling factors, E2F; '),(36,'E2f3','[MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=E2f3), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=E2f3), Glioma(https://www.kegg.jp/pathway/map=map05214&keyword=E2f3), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=E2f3), Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=E2f3), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=E2f3), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=E2f3), Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=E2f3), Hepatitis C(https://www.kegg.jp/pathway/map=map05160&keyword=E2f3), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=E2f3), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=E2f3), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=E2f3), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=E2f3), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=E2f3), Pancreatic cancer(https://www.kegg.jp/pathway/map=map05212&keyword=E2f3), Prostate cancer(https://www.kegg.jp/pathway/map=map05215&keyword=E2f3), Melanoma(https://www.kegg.jp/pathway/map=map05218&keyword=E2f3), Bladder cancer(https://www.kegg.jp/pathway/map=map05219&keyword=E2f3), Chronic myeloid leukemia(https://www.kegg.jp/pathway/map=map05220&keyword=E2f3), Small cell lung cancer(https://www.kegg.jp/pathway/map=map05222&keyword=E2f3)]','04110 Cell cycle; 04218 Cellular senescence; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05220 Chronic myeloid leukemia; 05218 Melanoma; 05219 Bladder cancer; 05215 Prostate cancer; 05224 Breast cancer; 05222 Small cell lung cancer; 05223 Non-small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 04934 Cushing syndrome; 01522 Endocrine resistance; 03000 Transcription factors [BR:mmu03000]; Fork head/winged helix cell cycle-controlling factors, E2F; '),(37,'EGFR','[<font color=\"red\">EGFR</font> tyrosine kinase inhibitor resistance(https://www.kegg.jp/pathway/map=map01521&keyword=EGFR), VEGF signaling pathway(https://www.kegg.jp/pathway/map=map04370&keyword=EGFR), Non-small cell lung cancer(https://www.kegg.jp/pathway/map=map05223&keyword=EGFR), ErbB signaling pathway(https://www.kegg.jp/pathway/map=map04012&keyword=EGFR), Breast cancer(https://www.kegg.jp/pathway/map=map05224&keyword=EGFR), Glioma(https://www.kegg.jp/pathway/map=map05214&keyword=EGFR), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=EGFR), Pancreatic cancer(https://www.kegg.jp/pathway/map=map05212&keyword=EGFR), MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=EGFR), Proteoglycans in cancer(https://www.kegg.jp/pathway/map=map05205&keyword=EGFR), Shigellosis(https://www.kegg.jp/pathway/map=map05131&keyword=EGFR), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=EGFR), Central carbon metabolism in cancer(https://www.kegg.jp/pathway/map=map05230&keyword=EGFR), Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=EGFR), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=EGFR), MAPK signaling pathway - fly(https://www.kegg.jp/pathway/map=map04013&keyword=EGFR), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=EGFR), Endocytosis(https://www.kegg.jp/pathway/map=map04144&keyword=EGFR), Apoptosis - fly(https://www.kegg.jp/pathway/map=map04214&keyword=EGFR), Dorso-ventral axis formation(https://www.kegg.jp/pathway/map=map04320&keyword=EGFR)]','04010 MAPK signaling pathway; 04012 ErbB signaling pathway; 04014 Ras signaling pathway; 04015 Rap1 signaling pathway; 04630 JAK-STAT signaling pathway; 04066 HIF-1 signaling pathway; 04068 FoxO signaling pathway; 04020 Calcium signaling pathway; 04072 Phospholipase D signaling pathway; 04151 PI3K-Akt signaling pathway; 04144 Endocytosis; 04510 Focal adhesion; 04520 Adherens junction; 04540 Gap junction; 04810 Regulation of actin cytoskeleton; 04912 GnRH signaling pathway; 04915 Estrogen signaling pathway; 04921 Oxytocin signaling pathway; 04926 Relaxin signaling pathway; 04928 Parathyroid hormone synthesis, secretion and action; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05205 Proteoglycans in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05230 Central carbon metabolism in cancer; 05231 Choline metabolism in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05218 Melanoma; 05219 Bladder cancer; 05215 Prostate cancer; 05213 Endometrial cancer; 05224 Breast cancer; 05223 Non-small cell lung cancer; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05163 Human cytomegalovirus infection; 05165 Human papillomavirus infection; 05120 Epithelial cell signaling in Helicobacter pylori infection; 05131 Shigellosis; 04934 Cushing syndrome; 01521 EGFR tyrosine kinase inhibitor resistance; 01522 Endocrine resistance; 01001 Protein kinases [BR:hsa01001]; 04147 Exosome [BR:hsa04147]; 2.7.10.1  receptor protein-tyrosine kinase; EGFR family [OT]; Exosomal proteins of colorectal cancer cells; Exosomal proteins of pancreatic cancer cells; Exosomal proteins of bladder cancer cells; '),(38,'Egr1','[Cell adhesion molecules(https://www.kegg.jp/pathway/map=map04514&keyword=Egr1), Apelin signaling pathway(https://www.kegg.jp/pathway/map=map04371&keyword=Egr1), Prion disease(https://www.kegg.jp/pathway/map=map05020&keyword=Egr1), GnRH signaling pathway(https://www.kegg.jp/pathway/map=map04912&keyword=Egr1), Parathyroid hormone synthesis, secretion and action(https://www.kegg.jp/pathway/map=map04928&keyword=Egr1), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Egr1), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Egr1)]','04371 Apelin signaling pathway; 04912 GnRH signaling pathway; 04928 Parathyroid hormone synthesis, secretion and action; 05166 Human T-cell leukemia virus 1 infection; 05020 Prion disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 03000 Transcription factors [BR:mmu03000]; Cys2His2 SP/KLF family and related proteins; '),(39,'Elp1','[]','03016 Transfer RNA biogenesis [BR:mmu03016]; Elongator complex; '),(40,'Ep300','[Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=Ep300), MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=Ep300), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Ep300), Renal cell carcinoma(https://www.kegg.jp/pathway/map=map05211&keyword=Ep300), Viral life cycle - HIV-1(https://www.kegg.jp/pathway/map=map03250&keyword=Ep300), cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=Ep300), HIF-1 signaling pathway(https://www.kegg.jp/pathway/map=map04066&keyword=Ep300), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Ep300), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Ep300), Wnt signaling pathway(https://www.kegg.jp/pathway/map=map04310&keyword=Ep300), Notch signaling pathway(https://www.kegg.jp/pathway/map=map04330&keyword=Ep300), TGF-beta signaling pathway(https://www.kegg.jp/pathway/map=map04350&keyword=Ep300), Adherens junction(https://www.kegg.jp/pathway/map=map04520&keyword=Ep300), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Ep300), Long-term potentiation(https://www.kegg.jp/pathway/map=map04720&keyword=Ep300), Melanogenesis(https://www.kegg.jp/pathway/map=map04916&keyword=Ep300), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Ep300), Glucagon signaling pathway(https://www.kegg.jp/pathway/map=map04922&keyword=Ep300), Growth hormone synthesis, secretion and action(https://www.kegg.jp/pathway/map=map04935&keyword=Ep300), Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=Ep300)]','03250 Viral life cycle - HIV-1; 04310 Wnt signaling pathway; 04330 Notch signaling pathway; 04350 TGF-beta signaling pathway; 04630 JAK-STAT signaling pathway; 04066 HIF-1 signaling pathway; 04068 FoxO signaling pathway; 04024 cAMP signaling pathway; 04110 Cell cycle; 04520 Adherens junction; 04922 Glucagon signaling pathway; 04935 Growth hormone synthesis, secretion and action; 04919 Thyroid hormone signaling pathway; 04916 Melanogenesis; 04720 Long-term potentiation; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05203 Viral carcinogenesis; 05211 Renal cell carcinoma; 05215 Prostate cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05164 Influenza A; 05167 Kaposi sarcoma-associated herpesvirus infection; 05165 Human papillomavirus infection; 05152 Tuberculosis; 05016 Huntington disease; 03000 Transcription factors [BR:mmu03000]; 03036 Chromosome and associated proteins [BR:mmu03036]; 03029 Mitochondrial biogenesis [BR:mmu03029]; 2.3.1.48  histone acetyltransferase; Pocket domain CBP; HATs (histone acetyltransferases); Coactivators; '),(41,'Esr1','[Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=Esr1), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=Esr1), Breast cancer(https://www.kegg.jp/pathway/map=map05224&keyword=Esr1), Estrogen signaling pathway(https://www.kegg.jp/pathway/map=map04915&keyword=Esr1), Prolactin signaling pathway(https://www.kegg.jp/pathway/map=map04917&keyword=Esr1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Esr1), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Esr1), Endocrine and other factor-regulated calcium reabsorption(https://www.kegg.jp/pathway/map=map04961&keyword=Esr1), Proteoglycans in cancer(https://www.kegg.jp/pathway/map=map05205&keyword=Esr1)]','04915 Estrogen signaling pathway; 04917 Prolactin signaling pathway; 04919 Thyroid hormone signaling pathway; 04961 Endocrine and other factor-regulated calcium reabsorption; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05207 Chemical carcinogenesis - receptor activation; 05224 Breast cancer; 01522 Endocrine resistance; 03000 Transcription factors [BR:mmu03000]; 03310 Nuclear receptors [BR:mmu03310]; Cys4 estrogen receptor-like; 3A. Estrogen receptor; '),(42,'Ets2','[Ras signaling pathway(https://www.kegg.jp/pathway/map=map04014&keyword=Ets2), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Ets2)]','04014 Ras signaling pathway; 05166 Human T-cell leukemia virus 1 infection; 03000 Transcription factors [BR:mmu03000]; Tryptophan clusters Ets-type; '),(43,'Ezh2','[Lysine degradation(https://www.kegg.jp/pathway/map=map00310&keyword=Ezh2), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Ezh2), MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=Ezh2)]','00310 Lysine degradation; 05206 MicroRNAs in cancer; 03036 Chromosome and associated proteins [BR:mmu03036]; 2.1.1.356  [histone H3]-lysine27 N-trimethyltransferase; HKMTs (histone lysine methyltransferases); PRC2-EZH2 complex; '),(44,'Fas','[Apoptosis(https://www.kegg.jp/pathway/map=map04210&keyword=Fas), Graft-versus-host disease(https://www.kegg.jp/pathway/map=map05332&keyword=Fas), Necroptosis(https://www.kegg.jp/pathway/map=map04217&keyword=Fas), Regulation of lipolysis in adipocytes(https://www.kegg.jp/pathway/map=map04923&keyword=Fas), GABAergic synapse(https://www.kegg.jp/pathway/map=map04727&keyword=Fas), Ferroptosis(https://www.kegg.jp/pathway/map=map04216&keyword=Fas), Non-alcoholic fatty liver disease(https://www.kegg.jp/pathway/map=map04932&keyword=Fas), Autoimmune thyroid disease(https://www.kegg.jp/pathway/map=map05320&keyword=Fas), Cortisol synthesis and secretion(https://www.kegg.jp/pathway/map=map04927&keyword=Fas), Proteasome(https://www.kegg.jp/pathway/map=map03050&keyword=Fas), Base excision repair(https://www.kegg.jp/pathway/map=map03410&keyword=Fas), Calcium signaling pathway(https://www.kegg.jp/pathway/map=map04020&keyword=Fas), Glutamatergic synapse(https://www.kegg.jp/pathway/map=map04724&keyword=Fas), Phototransduction - fly(https://www.kegg.jp/pathway/map=map04745&keyword=Fas), GnRH signaling pathway(https://www.kegg.jp/pathway/map=map04912&keyword=Fas), Adipocytokine signaling pathway(https://www.kegg.jp/pathway/map=map04920&keyword=Fas), Glucagon signaling pathway(https://www.kegg.jp/pathway/map=map04922&keyword=Fas), Fat digestion and absorption(https://www.kegg.jp/pathway/map=map04975&keyword=Fas), Fatty acid metabolism(https://www.kegg.jp/pathway/map=map01212&keyword=Fas), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Fas)]','04010 MAPK signaling pathway; 04668 TNF signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04210 Apoptosis; 04217 Necroptosis; 04115 p53 signaling pathway; 04650 Natural killer cell mediated cytotoxicity; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05142 Chagas disease; 05143 African trypanosomiasis; 05320 Autoimmune thyroid disease; 05330 Allograft rejection; 05332 Graft-versus-host disease; 05010 Alzheimer disease; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 04940 Type I diabetes mellitus; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 01524 Platinum drug resistance; 04050 Cytokine receptors [BR:mmu04050]; 04090 CD molecules [BR:mmu04090]; TNF receptor superfamily; Proteins; '),(45,'Fbxw7','[Ubiquitin mediated proteolysis(https://www.kegg.jp/pathway/map=map04120&keyword=Fbxw7)]','04120 Ubiquitin mediated proteolysis; 04131 Membrane trafficking [BR:mmu04131]; 04121 Ubiquitin system [BR:mmu04121]; Other mitophagy associated  proteins; Target recognizing subunit (F-box); '),(46,'Ffar2','[cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=Ffar2)]','04024 cAMP signaling pathway; 04030 G protein-coupled receptors [BR:mmu04030]; Free fatty acid; '),(47,'Ffar3','[]','04030 G protein-coupled receptors [BR:mmu04030]; Free fatty acid; '),(48,'Fgf15','[]','04010 MAPK signaling pathway; 04014 Ras signaling pathway; 04015 Rap1 signaling pathway; 04020 Calcium signaling pathway; 04151 PI3K-Akt signaling pathway; 04810 Regulation of actin cytoskeleton; 05200 Pathways in cancer; 05226 Gastric cancer; 05218 Melanoma; 05224 Breast cancer; 04052 Cytokines and growth factors [BR:mmu04052]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Growth factors (RTK binding); Growth factors/receptors; '),(49,'Fgfr4','[MAPK signaling pathway(https://www.kegg.jp/pathway/map=map04010&keyword=Fgfr4), Ras signaling pathway(https://www.kegg.jp/pathway/map=map04014&keyword=Fgfr4), Rap1 signaling pathway(https://www.kegg.jp/pathway/map=map04015&keyword=Fgfr4), Calcium signaling pathway(https://www.kegg.jp/pathway/map=map04020&keyword=Fgfr4), Endocytosis(https://www.kegg.jp/pathway/map=map04144&keyword=Fgfr4), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=Fgfr4), Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Fgfr4), Regulation of actin cytoskeleton(https://www.kegg.jp/pathway/map=map04810&keyword=Fgfr4), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Fgfr4)]','04010 MAPK signaling pathway; 04014 Ras signaling pathway; 04015 Rap1 signaling pathway; 04020 Calcium signaling pathway; 04151 PI3K-Akt signaling pathway; 04144 Endocytosis; 04550 Signaling pathways regulating pluripotency of stem cells; 04810 Regulation of actin cytoskeleton; 05200 Pathways in cancer; 01001 Protein kinases [BR:mmu01001]; 04090 CD molecules [BR:mmu04090]; 2.7.10.1  receptor protein-tyrosine kinase; FGFR family [OT]; Proteins; '),(50,'Fli1','[Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Fli1)]','05202 Transcriptional misregulation in cancer; 03000 Transcription factors [BR:mmu03000]; Tryptophan clusters Ets-type; '),(51,'Fn1','[ECM-receptor interaction(https://www.kegg.jp/pathway/map=map04512&keyword=Fn1), Proteoglycans in cancer(https://www.kegg.jp/pathway/map=map05205&keyword=Fn1), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=Fn1), Mitophagy - animal(https://www.kegg.jp/pathway/map=map04137&keyword=Fn1), Regulation of actin cytoskeleton(https://www.kegg.jp/pathway/map=map04810&keyword=Fn1), Parkinson disease(https://www.kegg.jp/pathway/map=map05012&keyword=Fn1), Pathways of neurodegeneration - multiple diseases(https://www.kegg.jp/pathway/map=map05022&keyword=Fn1), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=Fn1), Focal adhesion(https://www.kegg.jp/pathway/map=map04510&keyword=Fn1), NOD-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04621&keyword=Fn1), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Fn1), Bacterial invasion of epithelial cells(https://www.kegg.jp/pathway/map=map05100&keyword=Fn1), Yersinia infection(https://www.kegg.jp/pathway/map=map05135&keyword=Fn1), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=Fn1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Fn1), Small cell lung cancer(https://www.kegg.jp/pathway/map=map05222&keyword=Fn1), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Fn1), Amyotrophic lateral sclerosis(https://www.kegg.jp/pathway/map=map05014&keyword=Fn1)]','04151 PI3K-Akt signaling pathway; 04512 ECM-receptor interaction; 04510 Focal adhesion; 04810 Regulation of actin cytoskeleton; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05222 Small cell lung cancer; 05165 Human papillomavirus infection; 05135 Yersinia infection; 05100 Bacterial invasion of epithelial cells; 05146 Amoebiasis; 04933 AGE-RAGE signaling pathway in diabetic complications; 04131 Membrane trafficking [BR:mmu04131]; 04147 Exosome [BR:mmu04147]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; 04990 Domain-containing proteins not elsewhere classified [BR:mmu04990]; ER-Golgi intermediate compartment (ERGIC) proteins; Exosomal proteins of bladder cancer cells; Extracellular matrix molecules; Fibronectin type I domain-containing proteins; '),(52,'Fos','[Amphetamine addiction(https://www.kegg.jp/pathway/map=map05031&keyword=Fos), Phosphonate and phosphinate metabolism(https://www.kegg.jp/pathway/map=map00440&keyword=Fos), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=Fos), Drug metabolism - cytochrome P450(https://www.kegg.jp/pathway/map=map00982&keyword=Fos), Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=Fos), Anti-HIV agents(https://www.kegg.jp/pathway/map=map07053&keyword=Fos), HIV protease inhibitors(https://www.kegg.jp/pathway/map=map07218&keyword=Fos), Anticonvulsants(https://www.kegg.jp/pathway/map=map07033&keyword=Fos), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=Fos), Parathyroid hormone synthesis, secretion and action(https://www.kegg.jp/pathway/map=map04928&keyword=Fos), Growth hormone synthesis, secretion and action(https://www.kegg.jp/pathway/map=map04935&keyword=Fos), Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=Fos), MAPK signaling pathway(https://www.kegg.jp/pathway/map=map04010&keyword=Fos), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=Fos), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Fos), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Fos), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=Fos), Hypnotics(https://www.kegg.jp/pathway/map=map07032&keyword=Fos), Antiviral agents(https://www.kegg.jp/pathway/map=map07044&keyword=Fos), Renin-angiotensin system inhibitors(https://www.kegg.jp/pathway/map=map07217&keyword=Fos)]','04010 MAPK signaling pathway; 04668 TNF signaling pathway; 04024 cAMP signaling pathway; 04210 Apoptosis; 04620 Toll-like receptor signaling pathway; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04662 B cell receptor signaling pathway; 04915 Estrogen signaling pathway; 04917 Prolactin signaling pathway; 04921 Oxytocin signaling pathway; 04926 Relaxin signaling pathway; 04935 Growth hormone synthesis, secretion and action; 04928 Parathyroid hormone synthesis, secretion and action; 04725 Cholinergic synapse; 04728 Dopaminergic synapse; 04380 Osteoclast differentiation; 04713 Circadian entrainment; 05200 Pathways in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05231 Choline metabolism in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05210 Colorectal cancer; 05224 Breast cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05171 Coronavirus disease - COVID-19; 05162 Measles; 05167 Kaposi sarcoma-associated herpesvirus infection; 05132 Salmonella infection; 05135 Yersinia infection; 05133 Pertussis; 05140 Leishmaniasis; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05031 Amphetamine addiction; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 04932 Non-alcoholic fatty liver disease; 01522 Endocrine resistance; 03000 Transcription factors [BR:mmu03000]; 04131 Membrane trafficking [BR:mmu04131]; AP-1(-like) components, Fos; Selective cargos; '),(53,'FOS','[Amphetamine addiction(https://www.kegg.jp/pathway/map=map05031&keyword=FOS), Phosphonate and phosphinate metabolism(https://www.kegg.jp/pathway/map=map00440&keyword=FOS), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=FOS), Drug metabolism - cytochrome P450(https://www.kegg.jp/pathway/map=map00982&keyword=FOS), Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=FOS), Anti-HIV agents(https://www.kegg.jp/pathway/map=map07053&keyword=FOS), HIV protease inhibitors(https://www.kegg.jp/pathway/map=map07218&keyword=FOS), Anticonvulsants(https://www.kegg.jp/pathway/map=map07033&keyword=FOS), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=FOS), Parathyroid hormone synthesis, secretion and action(https://www.kegg.jp/pathway/map=map04928&keyword=FOS), Growth hormone synthesis, secretion and action(https://www.kegg.jp/pathway/map=map04935&keyword=FOS), Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=FOS), MAPK signaling pathway(https://www.kegg.jp/pathway/map=map04010&keyword=FOS), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=FOS), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=FOS), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=FOS), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=FOS), Hypnotics(https://www.kegg.jp/pathway/map=map07032&keyword=FOS), Antiviral agents(https://www.kegg.jp/pathway/map=map07044&keyword=FOS), Renin-angiotensin system inhibitors(https://www.kegg.jp/pathway/map=map07217&keyword=FOS)]','04010 MAPK signaling pathway; 04668 TNF signaling pathway; 04024 cAMP signaling pathway; 04210 Apoptosis; 04620 Toll-like receptor signaling pathway; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04662 B cell receptor signaling pathway; 04915 Estrogen signaling pathway; 04917 Prolactin signaling pathway; 04921 Oxytocin signaling pathway; 04926 Relaxin signaling pathway; 04935 Growth hormone synthesis, secretion and action; 04928 Parathyroid hormone synthesis, secretion and action; 04725 Cholinergic synapse; 04728 Dopaminergic synapse; 04380 Osteoclast differentiation; 04713 Circadian entrainment; 05200 Pathways in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05231 Choline metabolism in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05210 Colorectal cancer; 05224 Breast cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05171 Coronavirus disease - COVID-19; 05162 Measles; 05167 Kaposi sarcoma-associated herpesvirus infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05135 Yersinia infection; 05133 Pertussis; 05140 Leishmaniasis; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05031 Amphetamine addiction; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 04932 Non-alcoholic fatty liver disease; 01522 Endocrine resistance; 03000 Transcription factors [BR:hsa03000]; 04131 Membrane trafficking [BR:hsa04131]; AP-1(-like) components, Fos; Selective cargos; '),(54,'Foxa1','[]','03000 Transcription factors [BR:mmu03000]; Fork head/winged helix tissue-specific regulators; '),(55,'Foxm1','[Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=Foxm1)]','04218 Cellular senescence; 03000 Transcription factors [BR:mmu03000]; Fork head/winged helix other regulators; '),(56,'Foxo1','[FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Foxo1), Glucagon signaling pathway(https://www.kegg.jp/pathway/map=map04922&keyword=Foxo1), Insulin resistance(https://www.kegg.jp/pathway/map=map04931&keyword=Foxo1), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Foxo1), AMPK signaling pathway(https://www.kegg.jp/pathway/map=map04152&keyword=Foxo1), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Foxo1), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=Foxo1), Insulin signaling pathway(https://www.kegg.jp/pathway/map=map04910&keyword=Foxo1), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Foxo1), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=Foxo1), Longevity regulating pathway(https://www.kegg.jp/pathway/map=map04211&keyword=Foxo1), Longevity regulating pathway - multiple species(https://www.kegg.jp/pathway/map=map04213&keyword=Foxo1), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Foxo1), Shigellosis(https://www.kegg.jp/pathway/map=map05131&keyword=Foxo1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Foxo1), Prostate cancer(https://www.kegg.jp/pathway/map=map05215&keyword=Foxo1)]','04068 FoxO signaling pathway; 04152 AMPK signaling pathway; 04218 Cellular senescence; 04910 Insulin signaling pathway; 04922 Glucagon signaling pathway; 04919 Thyroid hormone signaling pathway; 04211 Longevity regulating pathway; 04213 Longevity regulating pathway - multiple species; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05215 Prostate cancer; 05165 Human papillomavirus infection; 04936 Alcoholic liver disease; 04931 Insulin resistance; 04933 AGE-RAGE signaling pathway in diabetic complications; 03000 Transcription factors [BR:mmu03000]; Fork head/winged helix other regulators; '),(57,'Foxo4','[FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Foxo4), Ras signaling pathway(https://www.kegg.jp/pathway/map=map04014&keyword=Foxo4), Shigellosis(https://www.kegg.jp/pathway/map=map05131&keyword=Foxo4)]','04014 Ras signaling pathway; 04068 FoxO signaling pathway; 03000 Transcription factors [BR:mmu03000]; Fork head/winged helix other regulators; '),(58,'Foxp3','[Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Foxp3), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Foxp3)]','04659 Th17 cell differentiation; 05321 Inflammatory bowel disease; 03000 Transcription factors [BR:mmu03000]; Fork head/winged helix other regulators; '),(59,'FOXP3','[Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=FOXP3), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=FOXP3)]','04659 Th17 cell differentiation; 05321 Inflammatory bowel disease; 03000 Transcription factors [BR:hsa03000]; Fork head/winged helix other regulators; '),(60,'Gata4','[Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=Gata4), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Gata4), cGMP-PKG signaling pathway(https://www.kegg.jp/pathway/map=map04022&keyword=Gata4), Tight junction(https://www.kegg.jp/pathway/map=map04530&keyword=Gata4)]','04022 cGMP-PKG signaling pathway; 04218 Cellular senescence; 04530 Tight junction; 04919 Thyroid hormone signaling pathway; 03000 Transcription factors [BR:mmu03000]; Cys4 GATA-factors; '),(61,'Gcg','[Neuroactive ligand-receptor interaction(https://www.kegg.jp/pathway/map=map04080&keyword=Gcg), Glucagon signaling pathway(https://www.kegg.jp/pathway/map=map04922&keyword=Gcg), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Gcg), ABC transporters(https://www.kegg.jp/pathway/map=map02010&keyword=Gcg), Hypertrophic cardiomyopathy(https://www.kegg.jp/pathway/map=map05410&keyword=Gcg), Arrhythmogenic right ventricular cardiomyopathy(https://www.kegg.jp/pathway/map=map05412&keyword=Gcg), Dilated cardiomyopathy(https://www.kegg.jp/pathway/map=map05414&keyword=Gcg), Viral myocarditis(https://www.kegg.jp/pathway/map=map05416&keyword=Gcg), Sphingolipid metabolism(https://www.kegg.jp/pathway/map=map00600&keyword=Gcg), Biosynthesis of enediyne antibiotics(https://www.kegg.jp/pathway/map=map01059&keyword=Gcg), Biosynthesis of secondary metabolites(https://www.kegg.jp/pathway/map=map01110&keyword=Gcg), cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=Gcg), Thermogenesis(https://www.kegg.jp/pathway/map=map04714&keyword=Gcg), Insulin secretion(https://www.kegg.jp/pathway/map=map04911&keyword=Gcg), Glycosphingolipid biosynthesis - lacto and neolacto series(https://www.kegg.jp/pathway/map=map00601&keyword=Gcg), Glycosphingolipid biosynthesis - globo and isoglobo series(https://www.kegg.jp/pathway/map=map00603&keyword=Gcg), Glycosphingolipid biosynthesis - ganglio series(https://www.kegg.jp/pathway/map=map00604&keyword=Gcg), AMPK signaling pathway(https://www.kegg.jp/pathway/map=map04152&keyword=Gcg)]','04024 cAMP signaling pathway; 04080 Neuroactive ligand-receptor interaction; 04911 Insulin secretion; 04922 Glucagon signaling pathway; 04714 Thermogenesis; '),(62,'Gfi1','[]','03000 Transcription factors [BR:mmu03000]; Cys2His2 others; '),(63,'Gli1','[Hedgehog signaling pathway(https://www.kegg.jp/pathway/map=map04340&keyword=Gli1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Gli1), Basal cell carcinoma(https://www.kegg.jp/pathway/map=map05217&keyword=Gli1), cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=Gli1)]','04340 Hedgehog signaling pathway; 04024 cAMP signaling pathway; 05200 Pathways in cancer; 05217 Basal cell carcinoma; 03000 Transcription factors [BR:mmu03000]; Cys2His2 GLI-like; '),(64,'GLP1R','[cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=GLP1R), Neuroactive ligand-receptor interaction(https://www.kegg.jp/pathway/map=map04080&keyword=GLP1R), Insulin secretion(https://www.kegg.jp/pathway/map=map04911&keyword=GLP1R)]','04024 cAMP signaling pathway; 04080 Neuroactive ligand-receptor interaction; 04911 Insulin secretion; 04030 G protein-coupled receptors [BR:hsa04030]; Glucagon; '),(65,'Grin1','[Amphetamine addiction(https://www.kegg.jp/pathway/map=map05031&keyword=Grin1), Neuroactive ligand-receptor interaction(https://www.kegg.jp/pathway/map=map04080&keyword=Grin1), Circadian entrainment(https://www.kegg.jp/pathway/map=map04713&keyword=Grin1), Spinocerebellar ataxia(https://www.kegg.jp/pathway/map=map05017&keyword=Grin1), Nicotine addiction(https://www.kegg.jp/pathway/map=map05033&keyword=Grin1), Alcoholism(https://www.kegg.jp/pathway/map=map05034&keyword=Grin1), Ras signaling pathway(https://www.kegg.jp/pathway/map=map04014&keyword=Grin1), Rap1 signaling pathway(https://www.kegg.jp/pathway/map=map04015&keyword=Grin1), Calcium signaling pathway(https://www.kegg.jp/pathway/map=map04020&keyword=Grin1), cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=Grin1), Long-term potentiation(https://www.kegg.jp/pathway/map=map04720&keyword=Grin1), Glutamatergic synapse(https://www.kegg.jp/pathway/map=map04724&keyword=Grin1), Alzheimer disease(https://www.kegg.jp/pathway/map=map05010&keyword=Grin1), Amyotrophic lateral sclerosis(https://www.kegg.jp/pathway/map=map05014&keyword=Grin1), Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=Grin1), Prion disease(https://www.kegg.jp/pathway/map=map05020&keyword=Grin1), Pathways of neurodegeneration - multiple diseases(https://www.kegg.jp/pathway/map=map05022&keyword=Grin1), Cocaine addiction(https://www.kegg.jp/pathway/map=map05030&keyword=Grin1)]','04014 Ras signaling pathway; 04015 Rap1 signaling pathway; 04020 Calcium signaling pathway; 04024 cAMP signaling pathway; 04080 Neuroactive ligand-receptor interaction; 04724 Glutamatergic synapse; 04720 Long-term potentiation; 04713 Circadian entrainment; 05010 Alzheimer disease; 05014 Amyotrophic lateral sclerosis; 05016 Huntington disease; 05017 Spinocerebellar ataxia; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05030 Cocaine addiction; 05031 Amphetamine addiction; 05033 Nicotine addiction; 05034 Alcoholism; 04040 Ion channels [BR:mmu04040]; Glutamate (ionotropic); '),(66,'Hcar2','[cAMP signaling pathway(https://www.kegg.jp/pathway/map=map04024&keyword=Hcar2)]','04024 cAMP signaling pathway; 04030 G protein-coupled receptors [BR:mmu04030]; Hydroxy-carboxylic acid; '),(67,'Hdac1','[Neutrophil extracellular trap formation(https://www.kegg.jp/pathway/map=map04613&keyword=Hdac1), Alcoholism(https://www.kegg.jp/pathway/map=map05034&keyword=Hdac1), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=Hdac1), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Hdac1), Amphetamine addiction(https://www.kegg.jp/pathway/map=map05031&keyword=Hdac1), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=Hdac1), MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=Hdac1), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Hdac1), Longevity regulating pathway - multiple species(https://www.kegg.jp/pathway/map=map04213&keyword=Hdac1), Notch signaling pathway(https://www.kegg.jp/pathway/map=map04330&keyword=Hdac1), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Hdac1), Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=Hdac1), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=Hdac1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Hdac1), Chronic myeloid leukemia(https://www.kegg.jp/pathway/map=map05220&keyword=Hdac1)]','04330 Notch signaling pathway; 04110 Cell cycle; 04613 Neutrophil extracellular trap formation; 04919 Thyroid hormone signaling pathway; 04213 Longevity regulating pathway - multiple species; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05206 MicroRNAs in cancer; 05203 Viral carcinogenesis; 05220 Chronic myeloid leukemia; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05016 Huntington disease; 05031 Amphetamine addiction; 05034 Alcoholism; 03036 Chromosome and associated proteins [BR:mmu03036]; 3.5.1.98  histone deacetylase; Class I HDACs; Sin3A-HDAC complex; BRAF-HDAC complex; Other heterochromatin formation proteins; NuRD complex; '),(68,'HDAC3','[Neutrophil extracellular trap formation(https://www.kegg.jp/pathway/map=map04613&keyword=HDAC3), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=HDAC3), Alcoholism(https://www.kegg.jp/pathway/map=map05034&keyword=HDAC3), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=HDAC3)]','04613 Neutrophil extracellular trap formation; 04919 Thyroid hormone signaling pathway; 05203 Viral carcinogenesis; 05034 Alcoholism; 03036 Chromosome and associated proteins [BR:hsa03036]; 3.5.1.98  histone deacetylase; Class I HDACs; '),(69,'Hdac5','[]','04371 Apelin signaling pathway; 04613 Neutrophil extracellular trap formation; 05206 MicroRNAs in cancer; 05203 Viral carcinogenesis; 05034 Alcoholism; 03036 Chromosome and associated proteins [BR:mmu03036]; 3.5.1.98  histone deacetylase; Class II HDACs; '),(70,'Hey1','[]','04330 Notch signaling pathway; 05200 Pathways in cancer; 05224 Breast cancer; 05165 Human papillomavirus infection; 03000 Transcription factors [BR:mmu03000]; Hairy, Hairy/E(SPL); '),(71,'Hic1','[]','03000 Transcription factors [BR:mmu03000]; Cys2His2 BTB-ZF factors; '),(72,'Hif1a','[Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Hif1a), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Hif1a), Renal cell carcinoma(https://www.kegg.jp/pathway/map=map05211&keyword=Hif1a), Central carbon metabolism in cancer(https://www.kegg.jp/pathway/map=map05230&keyword=Hif1a), HIF-1 signaling pathway(https://www.kegg.jp/pathway/map=map04066&keyword=Hif1a), Mitophagy - animal(https://www.kegg.jp/pathway/map=map04137&keyword=Hif1a), Autophagy - animal(https://www.kegg.jp/pathway/map=map04140&keyword=Hif1a), Longevity regulating pathway - worm(https://www.kegg.jp/pathway/map=map04212&keyword=Hif1a), Axon regeneration(https://www.kegg.jp/pathway/map=map04361&keyword=Hif1a), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=Hif1a), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Hif1a), Proteoglycans in cancer(https://www.kegg.jp/pathway/map=map05205&keyword=Hif1a), Chemical carcinogenesis - reactive oxygen species(https://www.kegg.jp/pathway/map=map05208&keyword=Hif1a), Choline metabolism in cancer(https://www.kegg.jp/pathway/map=map05231&keyword=Hif1a), PD-L1 expression and PD-1 checkpoint pathway in cancer(https://www.kegg.jp/pathway/map=map05235&keyword=Hif1a)]','04066 HIF-1 signaling pathway; 04140 Autophagy - animal; 04137 Mitophagy - animal; 04659 Th17 cell differentiation; 04919 Thyroid hormone signaling pathway; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05208 Chemical carcinogenesis - reactive oxygen species; 05230 Central carbon metabolism in cancer; 05231 Choline metabolism in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05211 Renal cell carcinoma; 05167 Kaposi sarcoma-associated herpesvirus infection; 03000 Transcription factors [BR:rno03000]; Factors with PAS domain; '),(73,'Hmgcr','[Bile secretion(https://www.kegg.jp/pathway/map=map04976&keyword=Hmgcr), Terpenoid backbone biosynthesis(https://www.kegg.jp/pathway/map=map00900&keyword=Hmgcr), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Hmgcr), Biosynthesis of secondary metabolites(https://www.kegg.jp/pathway/map=map01110&keyword=Hmgcr), AMPK signaling pathway(https://www.kegg.jp/pathway/map=map04152&keyword=Hmgcr)]','00900 Terpenoid backbone biosynthesis; 04152 AMPK signaling pathway; 04976 Bile secretion; 1.1.1.34  hydroxymethylglutaryl-CoA reductase (NADPH); '),(74,'Hnf1a','[Maturity onset diabetes of the young(https://www.kegg.jp/pathway/map=map04950&keyword=Hnf1a)]','04950 Maturity onset diabetes of the young; 03000 Transcription factors [BR:mmu03000]; Homeo domain POU; '),(75,'Hnf1b','[Maturity onset diabetes of the young(https://www.kegg.jp/pathway/map=map04950&keyword=Hnf1b)]','04950 Maturity onset diabetes of the young; 03000 Transcription factors [BR:mmu03000]; Homeo domain POU; '),(76,'Ido1','[]','00380 Tryptophan metabolism; 05143 African trypanosomiasis; 1.13.11.52  indoleamine 2,3-dioxygenase; '),(77,'IFNG','[Type I diabetes mellitus(https://www.kegg.jp/pathway/map=map04940&keyword=IFNG), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=IFNG), Natural killer cell mediated cytotoxicity(https://www.kegg.jp/pathway/map=map04650&keyword=IFNG), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=IFNG), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=IFNG), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=IFNG), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=IFNG), Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=IFNG), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=IFNG), Influenza A(https://www.kegg.jp/pathway/map=map05164&keyword=IFNG), Herpes simplex virus 1 infection(https://www.kegg.jp/pathway/map=map05168&keyword=IFNG), PD-L1 expression and PD-1 checkpoint pathway in cancer(https://www.kegg.jp/pathway/map=map05235&keyword=IFNG), HIF-1 signaling pathway(https://www.kegg.jp/pathway/map=map04066&keyword=IFNG), Necroptosis(https://www.kegg.jp/pathway/map=map04217&keyword=IFNG), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=IFNG), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=IFNG), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=IFNG), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=IFNG), Graft-versus-host disease(https://www.kegg.jp/pathway/map=map05332&keyword=IFNG), Proteasome(https://www.kegg.jp/pathway/map=map03050&keyword=IFNG)]','03050 Proteasome; 04350 TGF-beta signaling pathway; 04630 JAK-STAT signaling pathway; 04066 HIF-1 signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04217 Necroptosis; 04650 Natural killer cell mediated cytotoxicity; 04612 Antigen processing and presentation; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04380 Osteoclast differentiation; 05200 Pathways in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05160 Hepatitis C; 05164 Influenza A; 05168 Herpes simplex virus 1 infection; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05322 Systemic lupus erythematosus; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 05332 Graft-versus-host disease; 05418 Fluid shear stress and atherosclerosis; 04940 Type I diabetes mellitus; 03051 Proteasome [BR:hsa03051]; 04052 Cytokines and growth factors [BR:hsa04052]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Other assembling factors; Interferons; Cytokines; '),(78,'Il10','[Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=Il10), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Il10), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=Il10), C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=Il10), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=Il10), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Il10), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=Il10), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=Il10), Autoimmune thyroid disease(https://www.kegg.jp/pathway/map=map05320&keyword=Il10), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Il10), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=Il10), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=Il10), African trypanosomiasis(https://www.kegg.jp/pathway/map=map05143&keyword=Il10), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=Il10), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=Il10), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Il10), T cell receptor signaling pathway(https://www.kegg.jp/pathway/map=map04660&keyword=Il10), Pertussis(https://www.kegg.jp/pathway/map=map05133&keyword=Il10), Yersinia infection(https://www.kegg.jp/pathway/map=map05135&keyword=Il10), Staphylococcus aureus infection(https://www.kegg.jp/pathway/map=map05150&keyword=Il10)]','04630 JAK-STAT signaling pathway; 04068 FoxO signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04625 C-type lectin receptor signaling pathway; 04660 T cell receptor signaling pathway; 04672 Intestinal immune network for IgA production; 05135 Yersinia infection; 05133 Pertussis; 05150 Staphylococcus aureus infection; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05310 Asthma; 05322 Systemic lupus erythematosus; 05320 Autoimmune thyroid disease; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 04052 Cytokines and growth factors [BR:mmu04052]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Interleukins; Cytokines; '),(79,'IL10','[Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=IL10), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=IL10), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=IL10), C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=IL10), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=IL10), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=IL10), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=IL10), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=IL10), Autoimmune thyroid disease(https://www.kegg.jp/pathway/map=map05320&keyword=IL10), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=IL10), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=IL10), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=IL10), African trypanosomiasis(https://www.kegg.jp/pathway/map=map05143&keyword=IL10), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=IL10), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=IL10), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=IL10), T cell receptor signaling pathway(https://www.kegg.jp/pathway/map=map04660&keyword=IL10), Pertussis(https://www.kegg.jp/pathway/map=map05133&keyword=IL10), Yersinia infection(https://www.kegg.jp/pathway/map=map05135&keyword=IL10), Staphylococcus aureus infection(https://www.kegg.jp/pathway/map=map05150&keyword=IL10)]','04630 JAK-STAT signaling pathway; 04068 FoxO signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04625 C-type lectin receptor signaling pathway; 04660 T cell receptor signaling pathway; 04672 Intestinal immune network for IgA production; 05135 Yersinia infection; 05133 Pertussis; 05150 Staphylococcus aureus infection; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05310 Asthma; 05322 Systemic lupus erythematosus; 05320 Autoimmune thyroid disease; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 04052 Cytokines and growth factors [BR:hsa04052]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Interleukins; Cytokines; '),(80,'IL12A','[C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=IL12A), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=IL12A), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=IL12A), Pertussis(https://www.kegg.jp/pathway/map=map05133&keyword=IL12A), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=IL12A), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=IL12A), Measles(https://www.kegg.jp/pathway/map=map05162&keyword=IL12A), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=IL12A), RIG-I-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04622&keyword=IL12A), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=IL12A), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=IL12A), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=IL12A), Type I diabetes mellitus(https://www.kegg.jp/pathway/map=map04940&keyword=IL12A), Legionellosis(https://www.kegg.jp/pathway/map=map05134&keyword=IL12A), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=IL12A), African trypanosomiasis(https://www.kegg.jp/pathway/map=map05143&keyword=IL12A), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=IL12A), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=IL12A), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=IL12A), Influenza A(https://www.kegg.jp/pathway/map=map05164&keyword=IL12A)]','04630 JAK-STAT signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04620 Toll-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 05200 Pathways in cancer; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 05417 Lipid and atherosclerosis; 04940 Type I diabetes mellitus; 04936 Alcoholic liver disease; 04052 Cytokines and growth factors [BR:hsa04052]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Interleukins; Cytokines; '),(81,'Il12b','[C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=Il12b), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=Il12b), Pertussis(https://www.kegg.jp/pathway/map=map05133&keyword=Il12b), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=Il12b), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=Il12b), Measles(https://www.kegg.jp/pathway/map=map05162&keyword=Il12b), Proteoglycans in cancer(https://www.kegg.jp/pathway/map=map05205&keyword=Il12b), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Il12b), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=Il12b), RIG-I-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04622&keyword=Il12b), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Il12b), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=Il12b), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Il12b), Type I diabetes mellitus(https://www.kegg.jp/pathway/map=map04940&keyword=Il12b), Legionellosis(https://www.kegg.jp/pathway/map=map05134&keyword=Il12b), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=Il12b), African trypanosomiasis(https://www.kegg.jp/pathway/map=map05143&keyword=Il12b), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=Il12b), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=Il12b), Influenza A(https://www.kegg.jp/pathway/map=map05164&keyword=Il12b)]','04630 JAK-STAT signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04620 Toll-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 05417 Lipid and atherosclerosis; 04940 Type I diabetes mellitus; 04936 Alcoholic liver disease; 04052 Cytokines and growth factors [BR:mmu04052]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Interleukins; Cytokines; '),(82,'IL12B','[C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=IL12B), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=IL12B), Pertussis(https://www.kegg.jp/pathway/map=map05133&keyword=IL12B), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=IL12B), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=IL12B), Measles(https://www.kegg.jp/pathway/map=map05162&keyword=IL12B), Proteoglycans in cancer(https://www.kegg.jp/pathway/map=map05205&keyword=IL12B), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=IL12B), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=IL12B), RIG-I-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04622&keyword=IL12B), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=IL12B), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=IL12B), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=IL12B), Type I diabetes mellitus(https://www.kegg.jp/pathway/map=map04940&keyword=IL12B), Legionellosis(https://www.kegg.jp/pathway/map=map05134&keyword=IL12B), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=IL12B), African trypanosomiasis(https://www.kegg.jp/pathway/map=map05143&keyword=IL12B), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=IL12B), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=IL12B), Influenza A(https://www.kegg.jp/pathway/map=map05164&keyword=IL12B)]','04630 JAK-STAT signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04620 Toll-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 05417 Lipid and atherosclerosis; 04940 Type I diabetes mellitus; 04936 Alcoholic liver disease; 04052 Cytokines and growth factors [BR:hsa04052]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Interleukins; Cytokines; '),(83,'Il13','[Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Il13), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Il13), Asthma(https://www.kegg.jp/pathway/map=map05310&keyword=Il13), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Il13), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Il13), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=Il13), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=Il13), Fc epsilon RI signaling pathway(https://www.kegg.jp/pathway/map=map04664&keyword=Il13)]','04630 JAK-STAT signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04658 Th1 and Th2 cell differentiation; 04657 IL-17 signaling pathway; 04664 Fc epsilon RI signaling pathway; 05200 Pathways in cancer; 05310 Asthma; 05321 Inflammatory bowel disease; 04052 Cytokines and growth factors [BR:mmu04052]; Interleukins; '),(84,'IL17A','[Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=IL17A), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=IL17A), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=IL17A), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=IL17A), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=IL17A), Rheumatoid arthritis(https://www.kegg.jp/pathway/map=map05323&keyword=IL17A)]','04060 Cytokine-cytokine receptor interaction; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 04936 Alcoholic liver disease; 04052 Cytokines and growth factors [BR:hsa04052]; Interleukins; '),(85,'Il1b','[NOD-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04621&keyword=Il1b), C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=Il1b), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=Il1b), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=Il1b), Shigellosis(https://www.kegg.jp/pathway/map=map05131&keyword=Il1b), Pathogenic Escherichia coli infection(https://www.kegg.jp/pathway/map=map05130&keyword=Il1b), Pertussis(https://www.kegg.jp/pathway/map=map05133&keyword=Il1b), NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=Il1b), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=Il1b), Alzheimer disease(https://www.kegg.jp/pathway/map=map05010&keyword=Il1b), Salmonella infection(https://www.kegg.jp/pathway/map=map05132&keyword=Il1b), Legionellosis(https://www.kegg.jp/pathway/map=map05134&keyword=Il1b), Yersinia infection(https://www.kegg.jp/pathway/map=map05135&keyword=Il1b), Influenza A(https://www.kegg.jp/pathway/map=map05164&keyword=Il1b), Rheumatoid arthritis(https://www.kegg.jp/pathway/map=map05323&keyword=Il1b), Graft-versus-host disease(https://www.kegg.jp/pathway/map=map05332&keyword=Il1b), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Il1b), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=Il1b), Antifolate resistance(https://www.kegg.jp/pathway/map=map01523&keyword=Il1b), MAPK signaling pathway(https://www.kegg.jp/pathway/map=map04010&keyword=Il1b)]','04010 MAPK signaling pathway; 04064 NF-kappa B signaling pathway; 04668 TNF signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04217 Necroptosis; 04640 Hematopoietic cell lineage; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04623 Cytosolic DNA-sensing pathway; 04625 C-type lectin receptor signaling pathway; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04750 Inflammatory mediator regulation of TRP channels; 04380 Osteoclast differentiation; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05132 Salmonella infection; 05135 Yersinia infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05332 Graft-versus-host disease; 05010 Alzheimer disease; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 04940 Type I diabetes mellitus; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 01523 Antifolate resistance; 04052 Cytokines and growth factors [BR:mmu04052]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Interleukins; Cytokines; '),(86,'IL22','[Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=IL22), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=IL22), Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=IL22), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=IL22), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=IL22)]','04630 JAK-STAT signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04659 Th17 cell differentiation; 05321 Inflammatory bowel disease; 04052 Cytokines and growth factors [BR:hsa04052]; Interleukins; '),(87,'Il4','[Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Il4), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Il4), Hematopoietic cell lineage(https://www.kegg.jp/pathway/map=map04640&keyword=Il4), Asthma(https://www.kegg.jp/pathway/map=map05310&keyword=Il4), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=Il4), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Il4), Phenylalanine, tyrosine and tryptophan biosynthesis(https://www.kegg.jp/pathway/map=map00400&keyword=Il4), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=Il4), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Il4), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Il4), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=Il4), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Il4), Autoimmune thyroid disease(https://www.kegg.jp/pathway/map=map05320&keyword=Il4), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=Il4), Alanine, aspartate and glutamate metabolism(https://www.kegg.jp/pathway/map=map00250&keyword=Il4), Cysteine and methionine metabolism(https://www.kegg.jp/pathway/map=map00270&keyword=Il4), Valine, leucine and isoleucine degradation(https://www.kegg.jp/pathway/map=map00280&keyword=Il4), Tyrosine metabolism(https://www.kegg.jp/pathway/map=map00350&keyword=Il4), Phenylalanine metabolism(https://www.kegg.jp/pathway/map=map00360&keyword=Il4), Tryptophan metabolism(https://www.kegg.jp/pathway/map=map00380&keyword=Il4)]','04630 JAK-STAT signaling pathway; 04151 PI3K-Akt signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04640 Hematopoietic cell lineage; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04664 Fc epsilon RI signaling pathway; 04672 Intestinal immune network for IgA production; 05200 Pathways in cancer; 05140 Leishmaniasis; 05310 Asthma; 05320 Autoimmune thyroid disease; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 04052 Cytokines and growth factors [BR:mmu04052]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Interleukins; Cytokines; '),(88,'Il6','[Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=Il6), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=Il6), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Il6), Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=Il6), C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=Il6), Hematopoietic cell lineage(https://www.kegg.jp/pathway/map=map04640&keyword=Il6), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Il6), Rheumatoid arthritis(https://www.kegg.jp/pathway/map=map05323&keyword=Il6), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Il6), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Il6), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=Il6), Non-alcoholic fatty liver disease(https://www.kegg.jp/pathway/map=map04932&keyword=Il6), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=Il6), EGFR tyrosine kinase inhibitor resistance(https://www.kegg.jp/pathway/map=map01521&keyword=Il6), HIF-1 signaling pathway(https://www.kegg.jp/pathway/map=map04066&keyword=Il6), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=Il6), Cytosolic DNA-sensing pathway(https://www.kegg.jp/pathway/map=map04623&keyword=Il6), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=Il6), Insulin resistance(https://www.kegg.jp/pathway/map=map04931&keyword=Il6), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=Il6)]','04630 JAK-STAT signaling pathway; 04668 TNF signaling pathway; 04066 HIF-1 signaling pathway; 04068 FoxO signaling pathway; 04151 PI3K-Akt signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04218 Cellular senescence; 04640 Hematopoietic cell lineage; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04623 Cytosolic DNA-sensing pathway; 04625 C-type lectin receptor signaling pathway; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04672 Intestinal immune network for IgA production; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05132 Salmonella infection; 05135 Yersinia infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05142 Chagas disease; 05143 African trypanosomiasis; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05332 Graft-versus-host disease; 05010 Alzheimer disease; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 05410 Hypertrophic cardiomyopathy; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 04933 AGE-RAGE signaling pathway in diabetic complications; 01521 EGFR tyrosine kinase inhibitor resistance; 01523 Antifolate resistance; 04052 Cytokines and growth factors [BR:mmu04052]; Interleukins; '),(89,'Irf6','[]','03000 Transcription factors [BR:mmu03000]; 04147 Exosome [BR:mmu04147]; Tryptophan clusters interferon-regulating factors; Exosomal proteins of other body fluids (saliva and urine); '),(90,'JUN','[Gap <font color=\"red\">jun</font>ction(https://www.kegg.jp/pathway/map=map04540&keyword=JUN), Tight <font color=\"red\">jun</font>ction(https://www.kegg.jp/pathway/map=map04530&keyword=JUN), Adherens <font color=\"red\">jun</font>ction(https://www.kegg.jp/pathway/map=map04520&keyword=JUN), MAPK signaling pathway(https://www.kegg.jp/pathway/map=map04010&keyword=JUN), Wnt signaling pathway(https://www.kegg.jp/pathway/map=map04310&keyword=JUN), Focal adhesion(https://www.kegg.jp/pathway/map=map04510&keyword=JUN), GnRH signaling pathway(https://www.kegg.jp/pathway/map=map04912&keyword=JUN), MAPK signaling pathway - fly(https://www.kegg.jp/pathway/map=map04013&keyword=JUN), Homologous recombination(https://www.kegg.jp/pathway/map=map03440&keyword=JUN), Vibrio cholerae infection(https://www.kegg.jp/pathway/map=map05110&keyword=JUN), Carbon fixation pathways in prokaryotes(https://www.kegg.jp/pathway/map=map00720&keyword=JUN), mRNA surveillance pathway(https://www.kegg.jp/pathway/map=map03015&keyword=JUN), Rap1 signaling pathway(https://www.kegg.jp/pathway/map=map04015&keyword=JUN), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=JUN), Cardiac muscle contraction(https://www.kegg.jp/pathway/map=map04260&keyword=JUN), Leukocyte transendothelial migration(https://www.kegg.jp/pathway/map=map04670&keyword=JUN), Long-term depression(https://www.kegg.jp/pathway/map=map04730&keyword=JUN), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=JUN), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=JUN), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=JUN)]','04010 MAPK signaling pathway; 04012 ErbB signaling pathway; 04310 Wnt signaling pathway; 04668 TNF signaling pathway; 04024 cAMP signaling pathway; 04137 Mitophagy - animal; 04210 Apoptosis; 04510 Focal adhesion; 04530 Tight junction; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04662 B cell receptor signaling pathway; 04912 GnRH signaling pathway; 04915 Estrogen signaling pathway; 04921 Oxytocin signaling pathway; 04926 Relaxin signaling pathway; 04722 Neurotrophin signaling pathway; 04380 Osteoclast differentiation; 05200 Pathways in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05203 Viral carcinogenesis; 05231 Choline metabolism in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05210 Colorectal cancer; 05211 Renal cell carcinoma; 05224 Breast cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05171 Coronavirus disease - COVID-19; 05162 Measles; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05120 Epithelial cell signaling in Helicobacter pylori infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05131 Shigellosis; 05135 Yersinia infection; 05133 Pertussis; 05140 Leishmaniasis; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05030 Cocaine addiction; 05031 Amphetamine addiction; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 04932 Non-alcoholic fatty liver disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 01522 Endocrine resistance; 03000 Transcription factors [BR:hsa03000]; AP-1(-like) components, Jun; '),(91,'Klf2','[Fluid shear stress and atherosclerosis(https://www.kegg.jp/pathway/map=map05418&keyword=Klf2), Apelin signaling pathway(https://www.kegg.jp/pathway/map=map04371&keyword=Klf2), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Klf2)]','04371 Apelin signaling pathway; 04068 FoxO signaling pathway; 05418 Fluid shear stress and atherosclerosis; 03000 Transcription factors [BR:mmu03000]; Cys2His2 SP/KLF family and related proteins; '),(92,'Klf5','[Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=Klf5)]','05207 Chemical carcinogenesis - receptor activation; 03000 Transcription factors [BR:mmu03000]; Cys2His2 SP/KLF family and related proteins; '),(93,'Lef1','[Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Lef1), Gastric cancer(https://www.kegg.jp/pathway/map=map05226&keyword=Lef1), Wnt signaling pathway(https://www.kegg.jp/pathway/map=map04310&keyword=Lef1), Hippo signaling pathway(https://www.kegg.jp/pathway/map=map04390&keyword=Lef1), Adherens junction(https://www.kegg.jp/pathway/map=map04520&keyword=Lef1), Melanogenesis(https://www.kegg.jp/pathway/map=map04916&keyword=Lef1), Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=Lef1), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Lef1), Salmonella infection(https://www.kegg.jp/pathway/map=map05132&keyword=Lef1), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=Lef1), Colorectal cancer(https://www.kegg.jp/pathway/map=map05210&keyword=Lef1), Endometrial cancer(https://www.kegg.jp/pathway/map=map05213&keyword=Lef1), Prostate cancer(https://www.kegg.jp/pathway/map=map05215&keyword=Lef1), Thyroid cancer(https://www.kegg.jp/pathway/map=map05216&keyword=Lef1), Basal cell carcinoma(https://www.kegg.jp/pathway/map=map05217&keyword=Lef1), Acute myeloid leukemia(https://www.kegg.jp/pathway/map=map05221&keyword=Lef1), Breast cancer(https://www.kegg.jp/pathway/map=map05224&keyword=Lef1), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Lef1), Arrhythmogenic right ventricular cardiomyopathy(https://www.kegg.jp/pathway/map=map05412&keyword=Lef1)]','04310 Wnt signaling pathway; 04390 Hippo signaling pathway; 04520 Adherens junction; 04916 Melanogenesis; 05200 Pathways in cancer; 05210 Colorectal cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05216 Thyroid cancer; 05221 Acute myeloid leukemia; 05217 Basal cell carcinoma; 05215 Prostate cancer; 05213 Endometrial cancer; 05224 Breast cancer; 05167 Kaposi sarcoma-associated herpesvirus infection; 05132 Salmonella infection; 05412 Arrhythmogenic right ventricular cardiomyopathy; 04936 Alcoholic liver disease; 04934 Cushing syndrome; 03000 Transcription factors [BR:mmu03000]; HMG TCF-1; '),(94,'Lyl1','[Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Lyl1)]','05202 Transcriptional misregulation in cancer; 03000 Transcription factors [BR:mmu03000]; Tal/Twist/Atonal/Hen, Lymphoid factors; '),(95,'MAPK1','[IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=MAPK1), MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=MAPK1), Oocyte meiosis(https://www.kegg.jp/pathway/map=map04114&keyword=MAPK1)]','04010 MAPK signaling pathway; 04012 ErbB signaling pathway; 04014 Ras signaling pathway; 04015 Rap1 signaling pathway; 04350 TGF-beta signaling pathway; 04370 VEGF signaling pathway; 04371 Apelin signaling pathway; 04668 TNF signaling pathway; 04066 HIF-1 signaling pathway; 04068 FoxO signaling pathway; 04072 Phospholipase D signaling pathway; 04071 Sphingolipid signaling pathway; 04024 cAMP signaling pathway; 04022 cGMP-PKG signaling pathway; 04151 PI3K-Akt signaling pathway; 04150 mTOR signaling pathway; 04140 Autophagy - animal; 04114 Oocyte meiosis; 04210 Apoptosis; 04218 Cellular senescence; 04510 Focal adhesion; 04520 Adherens junction; 04540 Gap junction; 04550 Signaling pathways regulating pluripotency of stem cells; 04810 Regulation of actin cytoskeleton; 04611 Platelet activation; 04613 Neutrophil extracellular trap formation; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04650 Natural killer cell mediated cytotoxicity; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04662 B cell receptor signaling pathway; 04664 Fc epsilon RI signaling pathway; 04666 Fc gamma R-mediated phagocytosis; 04062 Chemokine signaling pathway; 04910 Insulin signaling pathway; 04929 GnRH secretion; 04912 GnRH signaling pathway; 04915 Estrogen signaling pathway; 04914 Progesterone-mediated oocyte maturation; 04917 Prolactin signaling pathway; 04921 Oxytocin signaling pathway; 04926 Relaxin signaling pathway; 04935 Growth hormone synthesis, secretion and action; 04919 Thyroid hormone signaling pathway; 04928 Parathyroid hormone synthesis, secretion and action; 04916 Melanogenesis; 04261 Adrenergic signaling in cardiomyocytes; 04270 Vascular smooth muscle contraction; 04960 Aldosterone-regulated sodium reabsorption; 04724 Glutamatergic synapse; 04725 Cholinergic synapse; 04726 Serotonergic synapse; 04720 Long-term potentiation; 04730 Long-term depression; 04723 Retrograde endocannabinoid signaling; 04722 Neurotrophin signaling pathway; 04360 Axon guidance; 04380 Osteoclast differentiation; 04713 Circadian entrainment; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05205 Proteoglycans in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05203 Viral carcinogenesis; 05230 Central carbon metabolism in cancer; 05231 Choline metabolism in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05216 Thyroid cancer; 05221 Acute myeloid leukemia; 05220 Chronic myeloid leukemia; 05218 Melanoma; 05211 Renal cell carcinoma; 05219 Bladder cancer; 05215 Prostate cancer; 05213 Endometrial cancer; 05224 Breast cancer; 05223 Non-small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05165 Human papillomavirus infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05131 Shigellosis; 05135 Yersinia infection; 05133 Pertussis; 05152 Tuberculosis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05010 Alzheimer disease; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05034 Alcoholism; 05417 Lipid and atherosclerosis; 04930 Type II diabetes mellitus; 04933 AGE-RAGE signaling pathway in diabetic complications; 04934 Cushing syndrome; 01521 EGFR tyrosine kinase inhibitor resistance; 01524 Platinum drug resistance; 01522 Endocrine resistance; 01001 Protein kinases [BR:hsa01001]; 03036 Chromosome and associated proteins [BR:hsa03036]; 04147 Exosome [BR:hsa04147]; 2.7.11.24  mitogen-activated protein kinase; MAPK family [OT]; Protein kinases; Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell); '),(96,'MAPK14','[]','04010 MAPK signaling pathway; 04015 Rap1 signaling pathway; 04370 VEGF signaling pathway; 04668 TNF signaling pathway; 04068 FoxO signaling pathway; 04071 Sphingolipid signaling pathway; 04114 Oocyte meiosis; 04218 Cellular senescence; 04550 Signaling pathways regulating pluripotency of stem cells; 04611 Platelet activation; 04613 Neutrophil extracellular trap formation; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04664 Fc epsilon RI signaling pathway; 04670 Leukocyte transendothelial migration; 04912 GnRH signaling pathway; 04914 Progesterone-mediated oocyte maturation; 04917 Prolactin signaling pathway; 04926 Relaxin signaling pathway; 04935 Growth hormone synthesis, secretion and action; 04261 Adrenergic signaling in cardiomyocytes; 04728 Dopaminergic synapse; 04723 Retrograde endocannabinoid signaling; 04722 Neurotrophin signaling pathway; 04750 Inflammatory mediator regulation of TRP channels; 04380 Osteoclast differentiation; 04714 Thermogenesis; 05205 Proteoglycans in cancer; 05208 Chemical carcinogenesis - reactive oxygen species; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05171 Coronavirus disease - COVID-19; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05120 Epithelial cell signaling in Helicobacter pylori infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05131 Shigellosis; 05135 Yersinia infection; 05133 Pertussis; 05152 Tuberculosis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05014 Amyotrophic lateral sclerosis; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 05415 Diabetic cardiomyopathy; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 01522 Endocrine resistance; 01001 Protein kinases [BR:hsa01001]; 2.7.11.24  mitogen-activated protein kinase; MAPK family [OT]; '),(97,'MAPK3','[]','04010 MAPK signaling pathway; 04012 ErbB signaling pathway; 04014 Ras signaling pathway; 04015 Rap1 signaling pathway; 04350 TGF-beta signaling pathway; 04370 VEGF signaling pathway; 04371 Apelin signaling pathway; 04668 TNF signaling pathway; 04066 HIF-1 signaling pathway; 04068 FoxO signaling pathway; 04072 Phospholipase D signaling pathway; 04071 Sphingolipid signaling pathway; 04024 cAMP signaling pathway; 04022 cGMP-PKG signaling pathway; 04151 PI3K-Akt signaling pathway; 04150 mTOR signaling pathway; 04140 Autophagy - animal; 04114 Oocyte meiosis; 04210 Apoptosis; 04218 Cellular senescence; 04510 Focal adhesion; 04520 Adherens junction; 04540 Gap junction; 04550 Signaling pathways regulating pluripotency of stem cells; 04810 Regulation of actin cytoskeleton; 04611 Platelet activation; 04613 Neutrophil extracellular trap formation; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04650 Natural killer cell mediated cytotoxicity; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04662 B cell receptor signaling pathway; 04664 Fc epsilon RI signaling pathway; 04666 Fc gamma R-mediated phagocytosis; 04062 Chemokine signaling pathway; 04910 Insulin signaling pathway; 04929 GnRH secretion; 04912 GnRH signaling pathway; 04915 Estrogen signaling pathway; 04914 Progesterone-mediated oocyte maturation; 04917 Prolactin signaling pathway; 04921 Oxytocin signaling pathway; 04926 Relaxin signaling pathway; 04935 Growth hormone synthesis, secretion and action; 04919 Thyroid hormone signaling pathway; 04928 Parathyroid hormone synthesis, secretion and action; 04916 Melanogenesis; 04261 Adrenergic signaling in cardiomyocytes; 04270 Vascular smooth muscle contraction; 04960 Aldosterone-regulated sodium reabsorption; 04724 Glutamatergic synapse; 04725 Cholinergic synapse; 04726 Serotonergic synapse; 04720 Long-term potentiation; 04730 Long-term depression; 04723 Retrograde endocannabinoid signaling; 04722 Neurotrophin signaling pathway; 04360 Axon guidance; 04380 Osteoclast differentiation; 04713 Circadian entrainment; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05205 Proteoglycans in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05203 Viral carcinogenesis; 05230 Central carbon metabolism in cancer; 05231 Choline metabolism in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05216 Thyroid cancer; 05221 Acute myeloid leukemia; 05220 Chronic myeloid leukemia; 05218 Melanoma; 05211 Renal cell carcinoma; 05219 Bladder cancer; 05215 Prostate cancer; 05213 Endometrial cancer; 05224 Breast cancer; 05223 Non-small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05165 Human papillomavirus infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05131 Shigellosis; 05135 Yersinia infection; 05133 Pertussis; 05152 Tuberculosis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05010 Alzheimer disease; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05034 Alcoholism; 05417 Lipid and atherosclerosis; 04930 Type II diabetes mellitus; 04933 AGE-RAGE signaling pathway in diabetic complications; 04934 Cushing syndrome; 01521 EGFR tyrosine kinase inhibitor resistance; 01524 Platinum drug resistance; 01522 Endocrine resistance; 01001 Protein kinases [BR:hsa01001]; 03036 Chromosome and associated proteins [BR:hsa03036]; 04147 Exosome [BR:hsa04147]; 2.7.11.24  mitogen-activated protein kinase; MAPK family [OT]; Protein kinases; Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell); '),(98,'Mnt','[ABC transporters(https://www.kegg.jp/pathway/map=map02010&keyword=Mnt), Other types of O-glycan biosynthesis(https://www.kegg.jp/pathway/map=map00514&keyword=Mnt), Two-component system(https://www.kegg.jp/pathway/map=map02020&keyword=Mnt)]','03000 Transcription factors [BR:mmu03000]; Cell cycle controlling factors, Mad/Max; '),(99,'Mta1','[Carbon metabolism(https://www.kegg.jp/pathway/map=map01200&keyword=Mta1), Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Mta1), Carbon fixation pathways in prokaryotes(https://www.kegg.jp/pathway/map=map00720&keyword=Mta1), Microbial metabolism in diverse environments(https://www.kegg.jp/pathway/map=map01120&keyword=Mta1), C5-Branched dibasic acid metabolism(https://www.kegg.jp/pathway/map=map00660&keyword=Mta1)]','03000 Transcription factors [BR:mmu03000]; 03036 Chromosome and associated proteins [BR:mmu03036]; Cys4 GATA-factors; NuRD complex; '),(100,'Mtdh','[]',NULL),(101,'Mtpn','[]',NULL),(102,'Mybl2','[Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=Mybl2)]','04218 Cellular senescence; 03000 Transcription factors [BR:mmu03000]; Tryptophan clusters Myb, Myb-factors; '),(103,'Myc','[Neo<font color=\"red\">myc</font>in, kana<font color=\"red\">myc</font>in and gentamicin biosynthesis(https://www.kegg.jp/pathway/map=map00524&keyword=Myc), Vanco<font color=\"red\">myc</font>in resistance(https://www.kegg.jp/pathway/map=map01502&keyword=Myc), Arabinogalactan biosynthesis - <font color=\"red\">Myc</font>obacterium(https://www.kegg.jp/pathway/map=map00572&keyword=Myc), Strepto<font color=\"red\">myc</font>in biosynthesis(https://www.kegg.jp/pathway/map=map00521&keyword=Myc), Biosynthesis of ansa<font color=\"red\">myc</font>ins(https://www.kegg.jp/pathway/map=map01051&keyword=Myc), Rifa<font color=\"red\">myc</font>ins(https://www.kegg.jp/pathway/map=map07023&keyword=Myc), Biosynthesis of vanco<font color=\"red\">myc</font>in group antibiotics(https://www.kegg.jp/pathway/map=map01055&keyword=Myc), Acarbose and valida<font color=\"red\">myc</font>in biosynthesis(https://www.kegg.jp/pathway/map=map00525&keyword=Myc), Carbapenem biosynthesis(https://www.kegg.jp/pathway/map=map00332&keyword=Myc), Prodigiosin biosynthesis(https://www.kegg.jp/pathway/map=map00333&keyword=Myc), Central carbon metabolism in cancer(https://www.kegg.jp/pathway/map=map05230&keyword=Myc), Small cell lung cancer(https://www.kegg.jp/pathway/map=map05222&keyword=Myc), Lipoarabinomannan (LAM) biosynthesis(https://www.kegg.jp/pathway/map=map00571&keyword=Myc), Longevity regulating pathway(https://www.kegg.jp/pathway/map=map04211&keyword=Myc), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Myc), Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Myc), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=Myc), Penicillin and cephalosporin biosynthesis(https://www.kegg.jp/pathway/map=map00311&keyword=Myc), Biosynthesis of enediyne antibiotics(https://www.kegg.jp/pathway/map=map01059&keyword=Myc), Sulfur relay system(https://www.kegg.jp/pathway/map=map04122&keyword=Myc)]','04010 MAPK signaling pathway; 04012 ErbB signaling pathway; 04310 Wnt signaling pathway; 04350 TGF-beta signaling pathway; 04390 Hippo signaling pathway; 04630 JAK-STAT signaling pathway; 04151 PI3K-Akt signaling pathway; 04110 Cell cycle; 04218 Cellular senescence; 04550 Signaling pathways regulating pluripotency of stem cells; 04919 Thyroid hormone signaling pathway; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05206 MicroRNAs in cancer; 05205 Proteoglycans in cancer; 05207 Chemical carcinogenesis - receptor activation; 05230 Central carbon metabolism in cancer; 05210 Colorectal cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05216 Thyroid cancer; 05221 Acute myeloid leukemia; 05220 Chronic myeloid leukemia; 05219 Bladder cancer; 05213 Endometrial cancer; 05224 Breast cancer; 05222 Small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05132 Salmonella infection; 03000 Transcription factors [BR:mmu03000]; 03019 Messenger RNA biogenesis [BR:mmu03019]; Cell cycle controlling factors, Myc; Factors that have mRNA localization signals; '),(104,'Nacc1','[]','04121 Ubiquitin system [BR:mmu04121]; Adoptor and target recognizing subunit (BTB); '),(105,'Neurog3','[Maturity onset diabetes of the young(https://www.kegg.jp/pathway/map=map04950&keyword=Neurog3)]','04950 Maturity onset diabetes of the young; 03000 Transcription factors [BR:mmu03000]; Tal/Twist/Atonal/Hen, Atonal; '),(106,'Nfe2l2','[Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Nfe2l2), Fluid shear stress and atherosclerosis(https://www.kegg.jp/pathway/map=map05418&keyword=Nfe2l2), Protein processing in endoplasmic reticulum(https://www.kegg.jp/pathway/map=map04141&keyword=Nfe2l2), Longevity regulating pathway - worm(https://www.kegg.jp/pathway/map=map04212&keyword=Nfe2l2), Parkinson disease(https://www.kegg.jp/pathway/map=map05012&keyword=Nfe2l2), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Nfe2l2), Chemical carcinogenesis - reactive oxygen species(https://www.kegg.jp/pathway/map=map05208&keyword=Nfe2l2), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=Nfe2l2)]','04141 Protein processing in endoplasmic reticulum; 05200 Pathways in cancer; 05208 Chemical carcinogenesis - reactive oxygen species; 05225 Hepatocellular carcinoma; 05012 Parkinson disease; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 03000 Transcription factors [BR:mmu03000]; 03029 Mitochondrial biogenesis [BR:mmu03029]; AP-1(-like) components, NF-E2; Nuclear respiratory factors; '),(107,'Nfkb1','[C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=Nfkb1), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=Nfkb1), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Nfkb1), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Nfkb1), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=Nfkb1), Herpes simplex virus 1 infection(https://www.kegg.jp/pathway/map=map05168&keyword=Nfkb1), NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=Nfkb1), NOD-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04621&keyword=Nfkb1), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=Nfkb1), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=Nfkb1), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=Nfkb1), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=Nfkb1), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=Nfkb1), PD-L1 expression and PD-1 checkpoint pathway in cancer(https://www.kegg.jp/pathway/map=map05235&keyword=Nfkb1), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Nfkb1), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=Nfkb1), Cytosolic DNA-sensing pathway(https://www.kegg.jp/pathway/map=map04623&keyword=Nfkb1), Toll and Imd signaling pathway(https://www.kegg.jp/pathway/map=map04624&keyword=Nfkb1), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=Nfkb1), Neurotrophin signaling pathway(https://www.kegg.jp/pathway/map=map04722&keyword=Nfkb1)]','04010 MAPK signaling pathway; 04014 Ras signaling pathway; 04064 NF-kappa B signaling pathway; 04668 TNF signaling pathway; 04066 HIF-1 signaling pathway; 04071 Sphingolipid signaling pathway; 04024 cAMP signaling pathway; 04151 PI3K-Akt signaling pathway; 04210 Apoptosis; 04218 Cellular senescence; 04613 Neutrophil extracellular trap formation; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04623 Cytosolic DNA-sensing pathway; 04625 C-type lectin receptor signaling pathway; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04662 B cell receptor signaling pathway; 04062 Chemokine signaling pathway; 04920 Adipocytokine signaling pathway; 04917 Prolactin signaling pathway; 04926 Relaxin signaling pathway; 04722 Neurotrophin signaling pathway; 04380 Osteoclast differentiation; 04211 Longevity regulating pathway; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05206 MicroRNAs in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05203 Viral carcinogenesis; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05212 Pancreatic cancer; 05221 Acute myeloid leukemia; 05220 Chronic myeloid leukemia; 05215 Prostate cancer; 05222 Small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05132 Salmonella infection; 05135 Yersinia infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05321 Inflammatory bowel disease; 05010 Alzheimer disease; 05022 Pathways of neurodegeneration - multiple diseases; 05030 Cocaine addiction; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 05415 Diabetic cardiomyopathy; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 04933 AGE-RAGE signaling pathway in diabetic complications; 01523 Antifolate resistance; 03000 Transcription factors [BR:mmu03000]; RHR (Rel homology region) Rel/Ankyrin; '),(108,'NFKB1','[C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=NFKB1), IL-17 signaling pathway(https://www.kegg.jp/pathway/map=map04657&keyword=NFKB1), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=NFKB1), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=NFKB1), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=NFKB1), Herpes simplex virus 1 infection(https://www.kegg.jp/pathway/map=map05168&keyword=NFKB1), NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=NFKB1), NOD-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04621&keyword=NFKB1), TNF signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=NFKB1), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=NFKB1), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=NFKB1), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=NFKB1), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=NFKB1), PD-L1 expression and PD-1 checkpoint pathway in cancer(https://www.kegg.jp/pathway/map=map05235&keyword=NFKB1), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=NFKB1), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=NFKB1), Cytosolic DNA-sensing pathway(https://www.kegg.jp/pathway/map=map04623&keyword=NFKB1), Toll and Imd signaling pathway(https://www.kegg.jp/pathway/map=map04624&keyword=NFKB1), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=NFKB1), Neurotrophin signaling pathway(https://www.kegg.jp/pathway/map=map04722&keyword=NFKB1)]','04010 MAPK signaling pathway; 04014 Ras signaling pathway; 04064 NF-kappa B signaling pathway; 04668 TNF signaling pathway; 04066 HIF-1 signaling pathway; 04071 Sphingolipid signaling pathway; 04024 cAMP signaling pathway; 04151 PI3K-Akt signaling pathway; 04210 Apoptosis; 04218 Cellular senescence; 04613 Neutrophil extracellular trap formation; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04623 Cytosolic DNA-sensing pathway; 04625 C-type lectin receptor signaling pathway; 04660 T cell receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04657 IL-17 signaling pathway; 04662 B cell receptor signaling pathway; 04062 Chemokine signaling pathway; 04920 Adipocytokine signaling pathway; 04917 Prolactin signaling pathway; 04926 Relaxin signaling pathway; 04722 Neurotrophin signaling pathway; 04380 Osteoclast differentiation; 04211 Longevity regulating pathway; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05206 MicroRNAs in cancer; 05207 Chemical carcinogenesis - receptor activation; 05208 Chemical carcinogenesis - reactive oxygen species; 05203 Viral carcinogenesis; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05212 Pancreatic cancer; 05221 Acute myeloid leukemia; 05220 Chronic myeloid leukemia; 05215 Prostate cancer; 05222 Small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05120 Epithelial cell signaling in Helicobacter pylori infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05131 Shigellosis; 05135 Yersinia infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05321 Inflammatory bowel disease; 05010 Alzheimer disease; 05022 Pathways of neurodegeneration - multiple diseases; 05030 Cocaine addiction; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 05415 Diabetic cardiomyopathy; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 04933 AGE-RAGE signaling pathway in diabetic complications; 01523 Antifolate resistance; 03000 Transcription factors [BR:hsa03000]; RHR (Rel homology region) Rel/Ankyrin; '),(109,'Nfya','[Antigen processing and presentation(https://www.kegg.jp/pathway/map=map04612&keyword=Nfya), Spinocerebellar ataxia(https://www.kegg.jp/pathway/map=map05017&keyword=Nfya), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=Nfya)]','04612 Antigen processing and presentation; 05152 Tuberculosis; 05017 Spinocerebellar ataxia; 03000 Transcription factors [BR:mmu03000]; Heteromeric CCAAT factors; '),(110,'Nos2','[Metabolic pathways(https://www.kegg.jp/pathway/map=map01100&keyword=Nos2), Arginine and proline metabolism(https://www.kegg.jp/pathway/map=map00330&keyword=Nos2), Apelin signaling pathway(https://www.kegg.jp/pathway/map=map04371&keyword=Nos2), Relaxin signaling pathway(https://www.kegg.jp/pathway/map=map04926&keyword=Nos2), Amyotrophic lateral sclerosis(https://www.kegg.jp/pathway/map=map05014&keyword=Nos2), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=Nos2), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=Nos2), Arginine biosynthesis(https://www.kegg.jp/pathway/map=map00220&keyword=Nos2), Biosynthesis of secondary metabolites(https://www.kegg.jp/pathway/map=map01110&keyword=Nos2), Calcium signaling pathway(https://www.kegg.jp/pathway/map=map04020&keyword=Nos2), HIF-1 signaling pathway(https://www.kegg.jp/pathway/map=map04066&keyword=Nos2), Peroxisome(https://www.kegg.jp/pathway/map=map04146&keyword=Nos2), Alzheimer disease(https://www.kegg.jp/pathway/map=map05010&keyword=Nos2), Pathways of neurodegeneration - multiple diseases(https://www.kegg.jp/pathway/map=map05022&keyword=Nos2), Pertussis(https://www.kegg.jp/pathway/map=map05133&keyword=Nos2), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=Nos2), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=Nos2), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=Nos2), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Nos2), Small cell lung cancer(https://www.kegg.jp/pathway/map=map05222&keyword=Nos2)]','00220 Arginine biosynthesis; 00330 Arginine and proline metabolism; 04371 Apelin signaling pathway; 04066 HIF-1 signaling pathway; 04020 Calcium signaling pathway; 04146 Peroxisome; 04926 Relaxin signaling pathway; 05200 Pathways in cancer; 05222 Small cell lung cancer; 05133 Pertussis; 05152 Tuberculosis; 05146 Amoebiasis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05010 Alzheimer disease; 05014 Amyotrophic lateral sclerosis; 05022 Pathways of neurodegeneration - multiple diseases; 1.14.13.39  nitric-oxide synthase (NADPH); '),(111,'Notch1','[Notch signaling pathway(https://www.kegg.jp/pathway/map=map04330&keyword=Notch1), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=Notch1), MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=Notch1), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=Notch1), Breast cancer(https://www.kegg.jp/pathway/map=map05224&keyword=Notch1), Endocrine resistance(https://www.kegg.jp/pathway/map=map01522&keyword=Notch1), Dorso-ventral axis formation(https://www.kegg.jp/pathway/map=map04320&keyword=Notch1), Axon regeneration(https://www.kegg.jp/pathway/map=map04361&keyword=Notch1), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Notch1), Prion disease(https://www.kegg.jp/pathway/map=map05020&keyword=Notch1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Notch1)]','04330 Notch signaling pathway; 04658 Th1 and Th2 cell differentiation; 04919 Thyroid hormone signaling pathway; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05224 Breast cancer; 05165 Human papillomavirus infection; 05020 Prion disease; 01522 Endocrine resistance; '),(112,'Nr1h4','[Bile secretion(https://www.kegg.jp/pathway/map=map04976&keyword=Nr1h4)]','04976 Bile secretion; 03000 Transcription factors [BR:mmu03000]; 03310 Nuclear receptors [BR:mmu03310]; Cys4 thyroid hormone receptor-like; 1H. Liver X receptor like receptor; '),(113,'NR1H4','[Bile secretion(https://www.kegg.jp/pathway/map=map04976&keyword=NR1H4)]','04976 Bile secretion; 03000 Transcription factors [BR:hsa03000]; 03310 Nuclear receptors [BR:hsa03310]; Cys4 thyroid hormone receptor-like; 1H. Liver X receptor like receptor; '),(114,'Nr3c1','[Neuroactive ligand-receptor interaction(https://www.kegg.jp/pathway/map=map04080&keyword=Nr3c1)]','04080 Neuroactive ligand-receptor interaction; 03000 Transcription factors [BR:mmu03000]; 03310 Nuclear receptors [BR:mmu03310]; Cys4 estrogen receptor-like; 3C. 3-Ketosteroid receptor; '),(115,'Ocln','[Tight junction(https://www.kegg.jp/pathway/map=map04530&keyword=Ocln), Cell adhesion molecules(https://www.kegg.jp/pathway/map=map04514&keyword=Ocln), Leukocyte transendothelial migration(https://www.kegg.jp/pathway/map=map04670&keyword=Ocln), Pathogenic Escherichia coli infection(https://www.kegg.jp/pathway/map=map05130&keyword=Ocln), Hepatitis C(https://www.kegg.jp/pathway/map=map05160&keyword=Ocln)]','04514 Cell adhesion molecules; 04530 Tight junction; 04670 Leukocyte transendothelial migration; 05160 Hepatitis C; 01009 Protein phosphatases and associated proteins [BR:mmu01009]; PP1-interacting proteins (PIPs); '),(116,'Onecut1','[Maturity onset diabetes of the young(https://www.kegg.jp/pathway/map=map04950&keyword=Onecut1), Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Onecut1)]','04550 Signaling pathways regulating pluripotency of stem cells; 04950 Maturity onset diabetes of the young; 03000 Transcription factors [BR:mmu03000]; Homeo domain CUT; '),(117,'Pdcd1lg2','[Cell adhesion molecules(https://www.kegg.jp/pathway/map=map04514&keyword=Pdcd1lg2)]','04514 Cell adhesion molecules; 04090 CD molecules [BR:mmu04090]; Proteins; '),(118,'Pdx1','[Maturity onset diabetes of the young(https://www.kegg.jp/pathway/map=map04950&keyword=Pdx1)]','04911 Insulin secretion; 04930 Type II diabetes mellitus; 04950 Maturity onset diabetes of the young; 03000 Transcription factors [BR:mmu03000]; Homeo domain ANTP: HOXL; '),(119,'Pgr','[Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Pgr), Toll and Imd signaling pathway(https://www.kegg.jp/pathway/map=map04624&keyword=Pgr), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=Pgr), Breast cancer(https://www.kegg.jp/pathway/map=map05224&keyword=Pgr), Oocyte meiosis(https://www.kegg.jp/pathway/map=map04114&keyword=Pgr), Estrogen signaling pathway(https://www.kegg.jp/pathway/map=map04915&keyword=Pgr), Progesterone-mediated oocyte maturation(https://www.kegg.jp/pathway/map=map04914&keyword=Pgr), Viral replication(https://www.kegg.jp/pathway/map=map03240&keyword=Pgr)]','04114 Oocyte meiosis; 04915 Estrogen signaling pathway; 04914 Progesterone-mediated oocyte maturation; 05207 Chemical carcinogenesis - receptor activation; 05224 Breast cancer; 03000 Transcription factors [BR:mmu03000]; 03310 Nuclear receptors [BR:mmu03310]; Cys4 estrogen receptor-like; 3C. 3-Ketosteroid receptor; '),(120,'Phf1','[]','03000 Transcription factors [BR:mmu03000]; 03036 Chromosome and associated proteins [BR:mmu03036]; Other zinc fingers; Other polycomb group proteins; '),(121,'Pias2','[Ubiquitin mediated proteolysis(https://www.kegg.jp/pathway/map=map04120&keyword=Pias2), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Pias2)]','04120 Ubiquitin mediated proteolysis; 04630 JAK-STAT signaling pathway; 04121 Ubiquitin system [BR:mmu04121]; 2.3.2.-; UBL E3 ligases; '),(122,'Plag1','[]','03000 Transcription factors [BR:mmu03000]; Cys2His2 others; '),(123,'Ppara','[PPAR signaling pathway(https://www.kegg.jp/pathway/map=map03320&keyword=Ppara), Renin secretion(https://www.kegg.jp/pathway/map=map04924&keyword=Ppara), DNA replication(https://www.kegg.jp/pathway/map=map03030&keyword=Ppara), Proteasome(https://www.kegg.jp/pathway/map=map03050&keyword=Ppara), N-Glycan biosynthesis(https://www.kegg.jp/pathway/map=map00510&keyword=Ppara)]','04024 cAMP signaling pathway; 04922 Glucagon signaling pathway; 04920 Adipocytokine signaling pathway; 03320 PPAR signaling pathway; 05207 Chemical carcinogenesis - receptor activation; 05160 Hepatitis C; 05415 Diabetic cardiomyopathy; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 03000 Transcription factors [BR:mmu03000]; 03310 Nuclear receptors [BR:mmu03310]; Cys4 thyroid hormone receptor-like; 1C. Peroxisome proliferator-activated receptor (PPAR); '),(124,'Pparg','[PPAR signaling pathway(https://www.kegg.jp/pathway/map=map03320&keyword=Pparg), AMPK signaling pathway(https://www.kegg.jp/pathway/map=map04152&keyword=Pparg), Glucagon signaling pathway(https://www.kegg.jp/pathway/map=map04922&keyword=Pparg), Insulin resistance(https://www.kegg.jp/pathway/map=map04931&keyword=Pparg), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Pparg), Longevity regulating pathway(https://www.kegg.jp/pathway/map=map04211&keyword=Pparg), Apelin signaling pathway(https://www.kegg.jp/pathway/map=map04371&keyword=Pparg), Thermogenesis(https://www.kegg.jp/pathway/map=map04714&keyword=Pparg), Insulin signaling pathway(https://www.kegg.jp/pathway/map=map04910&keyword=Pparg), Adipocytokine signaling pathway(https://www.kegg.jp/pathway/map=map04920&keyword=Pparg), Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=Pparg), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Pparg)]','04152 AMPK signaling pathway; 03320 PPAR signaling pathway; 04380 Osteoclast differentiation; 04211 Longevity regulating pathway; 04714 Thermogenesis; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05216 Thyroid cancer; 05016 Huntington disease; 05417 Lipid and atherosclerosis; 04932 Non-alcoholic fatty liver disease; 03000 Transcription factors [BR:mmu03000]; 03310 Nuclear receptors [BR:mmu03310]; Cys4 thyroid hormone receptor-like; 1C. Peroxisome proliferator-activated receptor (PPAR); '),(125,'Ppargc1a','[AMPK signaling pathway(https://www.kegg.jp/pathway/map=map04152&keyword=Ppargc1a), Glucagon signaling pathway(https://www.kegg.jp/pathway/map=map04922&keyword=Ppargc1a), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Ppargc1a), Longevity regulating pathway(https://www.kegg.jp/pathway/map=map04211&keyword=Ppargc1a), Insulin resistance(https://www.kegg.jp/pathway/map=map04931&keyword=Ppargc1a), Apelin signaling pathway(https://www.kegg.jp/pathway/map=map04371&keyword=Ppargc1a), Thermogenesis(https://www.kegg.jp/pathway/map=map04714&keyword=Ppargc1a), Insulin signaling pathway(https://www.kegg.jp/pathway/map=map04910&keyword=Ppargc1a), Adipocytokine signaling pathway(https://www.kegg.jp/pathway/map=map04920&keyword=Ppargc1a), Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=Ppargc1a)]','04371 Apelin signaling pathway; 04152 AMPK signaling pathway; 04910 Insulin signaling pathway; 04922 Glucagon signaling pathway; 04920 Adipocytokine signaling pathway; 04211 Longevity regulating pathway; 04714 Thermogenesis; 05016 Huntington disease; 04936 Alcoholic liver disease; 04931 Insulin resistance; 03029 Mitochondrial biogenesis [BR:mmu03029]; Coactivators; '),(126,'Prkaa1','[]','04371 Apelin signaling pathway; 04068 FoxO signaling pathway; 04151 PI3K-Akt signaling pathway; 04152 AMPK signaling pathway; 04150 mTOR signaling pathway; 04140 Autophagy - animal; 04530 Tight junction; 04910 Insulin signaling pathway; 04922 Glucagon signaling pathway; 04920 Adipocytokine signaling pathway; 04921 Oxytocin signaling pathway; 04211 Longevity regulating pathway; 04213 Longevity regulating pathway - multiple species; 04710 Circadian rhythm; 04714 Thermogenesis; 05418 Fluid shear stress and atherosclerosis; 05410 Hypertrophic cardiomyopathy; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 01001 Protein kinases [BR:mmu01001]; 04131 Membrane trafficking [BR:mmu04131]; 03029 Mitochondrial biogenesis [BR:mmu03029]; 2.7.11.11  cAMP-dependent protein kinase; CAMKL family; Others; Other regulator of mitochondrial biogenesis; Other mitophagy factors; '),(127,'Prkaa2','[]','04371 Apelin signaling pathway; 04068 FoxO signaling pathway; 04151 PI3K-Akt signaling pathway; 04152 AMPK signaling pathway; 04150 mTOR signaling pathway; 04140 Autophagy - animal; 04530 Tight junction; 04910 Insulin signaling pathway; 04922 Glucagon signaling pathway; 04920 Adipocytokine signaling pathway; 04921 Oxytocin signaling pathway; 04211 Longevity regulating pathway; 04213 Longevity regulating pathway - multiple species; 04710 Circadian rhythm; 04714 Thermogenesis; 05418 Fluid shear stress and atherosclerosis; 05410 Hypertrophic cardiomyopathy; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 01001 Protein kinases [BR:mmu01001]; 04131 Membrane trafficking [BR:mmu04131]; 03029 Mitochondrial biogenesis [BR:mmu03029]; 2.7.11.11  cAMP-dependent protein kinase; CAMKL family; Others; Other regulator of mitochondrial biogenesis; Other mitophagy factors; '),(128,'Pttg1','[]','04110 Cell cycle; 04114 Oocyte meiosis; 05166 Human T-cell leukemia virus 1 infection; 03036 Chromosome and associated proteins [BR:mmu03036]; Securin and associated proteins; '),(129,'Rb1','[Small cell lung cancer(https://www.kegg.jp/pathway/map=map05222&keyword=Rb1), Carbon metabolism(https://www.kegg.jp/pathway/map=map01200&keyword=Rb1), Bacterial secretion system(https://www.kegg.jp/pathway/map=map03070&keyword=Rb1), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Rb1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Rb1), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=Rb1), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Rb1), mTOR signaling pathway(https://www.kegg.jp/pathway/map=map04150&keyword=Rb1), Biosynthesis of secondary metabolites(https://www.kegg.jp/pathway/map=map01110&keyword=Rb1), Microbial metabolism in diverse environments(https://www.kegg.jp/pathway/map=map01120&keyword=Rb1), Calcium signaling pathway(https://www.kegg.jp/pathway/map=map04020&keyword=Rb1), Neuroactive ligand-receptor interaction(https://www.kegg.jp/pathway/map=map04080&keyword=Rb1), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=Rb1), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Rb1), Cushing syndrome(https://www.kegg.jp/pathway/map=map04934&keyword=Rb1), Salivary secretion(https://www.kegg.jp/pathway/map=map04970&keyword=Rb1), Hepatitis C(https://www.kegg.jp/pathway/map=map05160&keyword=Rb1), Chemical carcinogenesis - receptor activation(https://www.kegg.jp/pathway/map=map05207&keyword=Rb1), Glioma(https://www.kegg.jp/pathway/map=map05214&keyword=Rb1), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Rb1)]','04110 Cell cycle; 04218 Cellular senescence; 05200 Pathways in cancer; 05207 Chemical carcinogenesis - receptor activation; 05203 Viral carcinogenesis; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05220 Chronic myeloid leukemia; 05218 Melanoma; 05219 Bladder cancer; 05215 Prostate cancer; 05224 Breast cancer; 05222 Small cell lung cancer; 05223 Non-small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 04934 Cushing syndrome; 01522 Endocrine resistance; 01009 Protein phosphatases and associated proteins [BR:mmu01009]; 03000 Transcription factors [BR:mmu03000]; PP1-interacting proteins (PIPs); Pocket domain Rb; '),(130,'Rbl1','[Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Rbl1), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=Rbl1), TGF-beta signaling pathway(https://www.kegg.jp/pathway/map=map04350&keyword=Rbl1), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=Rbl1), Viral carcinogenesis(https://www.kegg.jp/pathway/map=map05203&keyword=Rbl1)]','04350 TGF-beta signaling pathway; 04110 Cell cycle; 04218 Cellular senescence; 05203 Viral carcinogenesis; 05165 Human papillomavirus infection; 03000 Transcription factors [BR:mmu03000]; Pocket domain Rb; '),(131,'Relb','[NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=Relb), C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=Relb), Antineoplastics - agents from natural products(https://www.kegg.jp/pathway/map=map07042&keyword=Relb), MAPK signaling pathway(https://www.kegg.jp/pathway/map=map04010&keyword=Relb), Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=Relb), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Relb), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=Relb)]','04010 MAPK signaling pathway; 04064 NF-kappa B signaling pathway; 04625 C-type lectin receptor signaling pathway; 04380 Osteoclast differentiation; 05166 Human T-cell leukemia virus 1 infection; 05169 Epstein-Barr virus infection; 03000 Transcription factors [BR:mmu03000]; RHR (Rel homology region) Rel/Ankyrin; '),(132,'Rnf2','[]','04121 Ubiquitin system [BR:mmu04121]; 03036 Chromosome and associated proteins [BR:mmu03036]; 2.3.2.27  RING-type E3 ubiquitin transferase; Other single Ring-finger type E3; PRC1 (polycomb repressive complex 1); AUTS2-polycomb complex; '),(133,'Sin3a','[Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Sin3a), Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=Sin3a), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=Sin3a), Mitophagy - yeast(https://www.kegg.jp/pathway/map=map04139&keyword=Sin3a), Thyroid hormone signaling pathway(https://www.kegg.jp/pathway/map=map04919&keyword=Sin3a)]','04919 Thyroid hormone signaling pathway; 05202 Transcriptional misregulation in cancer; 05169 Epstein-Barr virus infection; 05016 Huntington disease; 03036 Chromosome and associated proteins [BR:mmu03036]; Sin3A-HDAC complex; Other heterochromatin formation proteins; '),(134,'Sirpa','[Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=Sirpa)]','04380 Osteoclast differentiation; 04515 Cell adhesion molecules [BR:mmu04515]; 04090 CD molecules [BR:mmu04090]; SIRP family; Proteins; '),(135,'Slco4c1','[]','02000 Transporters [BR:mmu02000]; SLC21/ASLCO: Organic anion transporter; '),(136,'Smad2','[TGF-beta signaling pathway(https://www.kegg.jp/pathway/map=map04350&keyword=Smad2), Hippo signaling pathway(https://www.kegg.jp/pathway/map=map04390&keyword=Smad2), Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Smad2), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Smad2), Colorectal cancer(https://www.kegg.jp/pathway/map=map05210&keyword=Smad2), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Smad2), Endocytosis(https://www.kegg.jp/pathway/map=map04144&keyword=Smad2), Apelin signaling pathway(https://www.kegg.jp/pathway/map=map04371&keyword=Smad2), Relaxin signaling pathway(https://www.kegg.jp/pathway/map=map04926&keyword=Smad2), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Smad2), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=Smad2), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Smad2), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Smad2), Pancreatic cancer(https://www.kegg.jp/pathway/map=map05212&keyword=Smad2), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Smad2), Gastric cancer(https://www.kegg.jp/pathway/map=map05226&keyword=Smad2), Diabetic cardiomyopathy(https://www.kegg.jp/pathway/map=map05415&keyword=Smad2), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=Smad2), Proteoglycans in cancer(https://www.kegg.jp/pathway/map=map05205&keyword=Smad2), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Smad2)]','04350 TGF-beta signaling pathway; 04390 Hippo signaling pathway; 04371 Apelin signaling pathway; 04144 Endocytosis; 04110 Cell cycle; 04218 Cellular senescence; 04550 Signaling pathways regulating pluripotency of stem cells; 04659 Th17 cell differentiation; 04926 Relaxin signaling pathway; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05166 Human T-cell leukemia virus 1 infection; 05142 Chagas disease; 05321 Inflammatory bowel disease; 05415 Diabetic cardiomyopathy; 04933 AGE-RAGE signaling pathway in diabetic complications; '),(137,'Smad3','[TGF-beta signaling pathway(https://www.kegg.jp/pathway/map=map04350&keyword=Smad3), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Smad3), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Smad3), Hippo signaling pathway(https://www.kegg.jp/pathway/map=map04390&keyword=Smad3), Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Smad3), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Smad3), Wnt signaling pathway(https://www.kegg.jp/pathway/map=map04310&keyword=Smad3), Adherens junction(https://www.kegg.jp/pathway/map=map04520&keyword=Smad3), Chronic myeloid leukemia(https://www.kegg.jp/pathway/map=map05220&keyword=Smad3), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Smad3), Endocytosis(https://www.kegg.jp/pathway/map=map04144&keyword=Smad3), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=Smad3), Apelin signaling pathway(https://www.kegg.jp/pathway/map=map04371&keyword=Smad3), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Smad3), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Smad3), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Smad3), Colorectal cancer(https://www.kegg.jp/pathway/map=map05210&keyword=Smad3), Pancreatic cancer(https://www.kegg.jp/pathway/map=map05212&keyword=Smad3), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Smad3), Gastric cancer(https://www.kegg.jp/pathway/map=map05226&keyword=Smad3)]','04310 Wnt signaling pathway; 04350 TGF-beta signaling pathway; 04390 Hippo signaling pathway; 04371 Apelin signaling pathway; 04068 FoxO signaling pathway; 04144 Endocytosis; 04110 Cell cycle; 04218 Cellular senescence; 04520 Adherens junction; 04550 Signaling pathways regulating pluripotency of stem cells; 04659 Th17 cell differentiation; 05200 Pathways in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05220 Chronic myeloid leukemia; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05321 Inflammatory bowel disease; 05415 Diabetic cardiomyopathy; 04933 AGE-RAGE signaling pathway in diabetic complications; '),(138,'Smad4','[Pancreatic cancer(https://www.kegg.jp/pathway/map=map05212&keyword=Smad4), TGF-beta signaling pathway(https://www.kegg.jp/pathway/map=map04350&keyword=Smad4), Colorectal cancer(https://www.kegg.jp/pathway/map=map05210&keyword=Smad4), Hippo signaling pathway(https://www.kegg.jp/pathway/map=map04390&keyword=Smad4), Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Smad4), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Smad4), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Smad4), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Smad4), Wnt signaling pathway(https://www.kegg.jp/pathway/map=map04310&keyword=Smad4), Apelin signaling pathway(https://www.kegg.jp/pathway/map=map04371&keyword=Smad4), Adherens junction(https://www.kegg.jp/pathway/map=map04520&keyword=Smad4), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Smad4), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Smad4), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Smad4), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Smad4), Chronic myeloid leukemia(https://www.kegg.jp/pathway/map=map05220&keyword=Smad4), Hepatocellular carcinoma(https://www.kegg.jp/pathway/map=map05225&keyword=Smad4), Gastric cancer(https://www.kegg.jp/pathway/map=map05226&keyword=Smad4)]','04310 Wnt signaling pathway; 04350 TGF-beta signaling pathway; 04390 Hippo signaling pathway; 04371 Apelin signaling pathway; 04068 FoxO signaling pathway; 04110 Cell cycle; 04520 Adherens junction; 04550 Signaling pathways regulating pluripotency of stem cells; 04659 Th17 cell differentiation; 05200 Pathways in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05220 Chronic myeloid leukemia; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 04933 AGE-RAGE signaling pathway in diabetic complications; '),(139,'Sod1','[Amyotrophic lateral sclerosis(https://www.kegg.jp/pathway/map=map05014&keyword=Sod1), Pathways of neurodegeneration - multiple diseases(https://www.kegg.jp/pathway/map=map05022&keyword=Sod1), Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=Sod1), Peroxisome(https://www.kegg.jp/pathway/map=map04146&keyword=Sod1), Longevity regulating pathway - multiple species(https://www.kegg.jp/pathway/map=map04213&keyword=Sod1), Parkinson disease(https://www.kegg.jp/pathway/map=map05012&keyword=Sod1), Prion disease(https://www.kegg.jp/pathway/map=map05020&keyword=Sod1), Chemical carcinogenesis - reactive oxygen species(https://www.kegg.jp/pathway/map=map05208&keyword=Sod1)]','04146 Peroxisome; 04213 Longevity regulating pathway - multiple species; 05208 Chemical carcinogenesis - reactive oxygen species; 05012 Parkinson disease; 05014 Amyotrophic lateral sclerosis; 05016 Huntington disease; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 1.15.1.1  superoxide dismutase; '),(140,'Sox11','[]','03000 Transcription factors [BR:mmu03000]; HMG SOX; '),(141,'Srebf1','[]','04152 AMPK signaling pathway; 04910 Insulin signaling pathway; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 03000 Transcription factors [BR:mmu03000]; 04131 Membrane trafficking [BR:mmu04131]; Ubiquitous bHLH-ZIP factors; Other mitophagy associated  proteins; '),(142,'Srebf2','[]','03000 Transcription factors [BR:mmu03000]; Ubiquitous bHLH-ZIP factors; '),(143,'Stat1','[Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Stat1), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Stat1), Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=Stat1), C-type lectin receptor signaling pathway(https://www.kegg.jp/pathway/map=map04625&keyword=Stat1), Influenza A(https://www.kegg.jp/pathway/map=map05164&keyword=Stat1), Human papillomavirus infection(https://www.kegg.jp/pathway/map=map05165&keyword=Stat1), Herpes simplex virus 1 infection(https://www.kegg.jp/pathway/map=map05168&keyword=Stat1), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=Stat1), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Stat1), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=Stat1), NOD-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04621&keyword=Stat1), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=Stat1), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Stat1), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=Stat1), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=Stat1), Hepatitis C(https://www.kegg.jp/pathway/map=map05160&keyword=Stat1), Measles(https://www.kegg.jp/pathway/map=map05162&keyword=Stat1), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=Stat1), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=Stat1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Stat1)]','04630 JAK-STAT signaling pathway; 04217 Necroptosis; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04658 Th1 and Th2 cell differentiation; 04659 Th17 cell differentiation; 04062 Chemokine signaling pathway; 04917 Prolactin signaling pathway; 04935 Growth hormone synthesis, secretion and action; 04919 Thyroid hormone signaling pathway; 04380 Osteoclast differentiation; 05200 Pathways in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05212 Pancreatic cancer; 05161 Hepatitis B; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05152 Tuberculosis; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05321 Inflammatory bowel disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 03000 Transcription factors [BR:mmu03000]; STAT; '),(144,'Stat3','[Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Stat3), Adipocytokine signaling pathway(https://www.kegg.jp/pathway/map=map04920&keyword=Stat3), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=Stat3), PD-L1 expression and PD-1 checkpoint pathway in cancer(https://www.kegg.jp/pathway/map=map05235&keyword=Stat3), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Stat3), JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Stat3), EGFR tyrosine kinase inhibitor resistance(https://www.kegg.jp/pathway/map=map01521&keyword=Stat3), Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Stat3), Insulin resistance(https://www.kegg.jp/pathway/map=map04931&keyword=Stat3), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Stat3), Human cytomegalovirus infection(https://www.kegg.jp/pathway/map=map05163&keyword=Stat3), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=Stat3), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Stat3), HIF-1 signaling pathway(https://www.kegg.jp/pathway/map=map04066&keyword=Stat3), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Stat3), Hepatitis C(https://www.kegg.jp/pathway/map=map05160&keyword=Stat3), Measles(https://www.kegg.jp/pathway/map=map05162&keyword=Stat3), Kaposi sarcoma-associated herpesvirus infection(https://www.kegg.jp/pathway/map=map05167&keyword=Stat3), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=Stat3), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Stat3)]','04630 JAK-STAT signaling pathway; 04066 HIF-1 signaling pathway; 04068 FoxO signaling pathway; 04217 Necroptosis; 04550 Signaling pathways regulating pluripotency of stem cells; 04659 Th17 cell differentiation; 04062 Chemokine signaling pathway; 04920 Adipocytokine signaling pathway; 04917 Prolactin signaling pathway; 04935 Growth hormone synthesis, secretion and action; 05200 Pathways in cancer; 05206 MicroRNAs in cancer; 05205 Proteoglycans in cancer; 05207 Chemical carcinogenesis - receptor activation; 05203 Viral carcinogenesis; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05212 Pancreatic cancer; 05221 Acute myeloid leukemia; 05223 Non-small cell lung cancer; 05161 Hepatitis B; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05162 Measles; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05145 Toxoplasmosis; 05321 Inflammatory bowel disease; 05417 Lipid and atherosclerosis; 04931 Insulin resistance; 04933 AGE-RAGE signaling pathway in diabetic complications; 01521 EGFR tyrosine kinase inhibitor resistance; 03000 Transcription factors [BR:mmu03000]; STAT; '),(145,'Stat4','[JAK-STAT signaling pathway(https://www.kegg.jp/pathway/map=map04630&keyword=Stat4), Th1 and Th2 cell differentiation(https://www.kegg.jp/pathway/map=map04658&keyword=Stat4), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Stat4), Necroptosis(https://www.kegg.jp/pathway/map=map04217&keyword=Stat4), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Stat4), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Stat4)]','04630 JAK-STAT signaling pathway; 04217 Necroptosis; 04658 Th1 and Th2 cell differentiation; 05200 Pathways in cancer; 05161 Hepatitis B; 05321 Inflammatory bowel disease; 03000 Transcription factors [BR:mmu03000]; STAT; '),(146,'Taf4','[Huntington disease(https://www.kegg.jp/pathway/map=map05016&keyword=Taf4), Basal transcription factors(https://www.kegg.jp/pathway/map=map03022&keyword=Taf4)]','03022 Basal transcription factors; 05016 Huntington disease; 03021 Transcription machinery [BR:mmu03021]; 03036 Chromosome and associated proteins [BR:mmu03036]; TFIID; SAGA/TFTC/STAGA complex; TFTC complex; '),(147,'Tcf3','[Signaling pathways regulating pluripotency of stem cells(https://www.kegg.jp/pathway/map=map04550&keyword=Tcf3), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Tcf3), Human T-cell leukemia virus 1 infection(https://www.kegg.jp/pathway/map=map05166&keyword=Tcf3)]','04550 Signaling pathways regulating pluripotency of stem cells; 05202 Transcriptional misregulation in cancer; 05166 Human T-cell leukemia virus 1 infection; 03000 Transcription factors [BR:mmu03000]; Ubiquitous (class A) factors; '),(148,'Tcf4','[]','03000 Transcription factors [BR:mmu03000]; Ubiquitous (class A) factors; '),(149,'Tfap2c','[]','03000 Transcription factors [BR:mmu03000]; AP-2 (bHSH); '),(150,'Tfdp1','[Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Tfdp1), TGF-beta signaling pathway(https://www.kegg.jp/pathway/map=map04350&keyword=Tfdp1)]','04350 TGF-beta signaling pathway; 04110 Cell cycle; 03000 Transcription factors [BR:mmu03000]; Fork head/winged helix cell cycle-controlling factors, DP; '),(151,'Tgfb1','[Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=Tgfb1), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Tgfb1), Diabetic cardiomyopathy(https://www.kegg.jp/pathway/map=map05415&keyword=Tgfb1), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=Tgfb1), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=Tgfb1), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Tgfb1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Tgfb1), Renal cell carcinoma(https://www.kegg.jp/pathway/map=map05211&keyword=Tgfb1), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Tgfb1), MAPK signaling pathway(https://www.kegg.jp/pathway/map=map04010&keyword=Tgfb1), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=Tgfb1), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Tgfb1), TGF-beta signaling pathway(https://www.kegg.jp/pathway/map=map04350&keyword=Tgfb1), Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=Tgfb1), Hippo signaling pathway(https://www.kegg.jp/pathway/map=map04390&keyword=Tgfb1), Relaxin signaling pathway(https://www.kegg.jp/pathway/map=map04926&keyword=Tgfb1), Non-alcoholic fatty liver disease(https://www.kegg.jp/pathway/map=map04932&keyword=Tgfb1), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=Tgfb1), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=Tgfb1), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=Tgfb1)]','04010 MAPK signaling pathway; 04350 TGF-beta signaling pathway; 04390 Hippo signaling pathway; 04068 FoxO signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04110 Cell cycle; 04218 Cellular senescence; 04659 Th17 cell differentiation; 04672 Intestinal immune network for IgA production; 04926 Relaxin signaling pathway; 04380 Osteoclast differentiation; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05220 Chronic myeloid leukemia; 05211 Renal cell carcinoma; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05410 Hypertrophic cardiomyopathy; 05414 Dilated cardiomyopathy; 05415 Diabetic cardiomyopathy; 04932 Non-alcoholic fatty liver disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 03110 Chaperones and folding catalysts [BR:mmu03110]; 04052 Cytokines and growth factors [BR:mmu04052]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Others; Transforming growth factors (RSTK binding); Growth factors/receptors; '),(152,'TGFB1','[Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=TGFB1), Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=TGFB1), Diabetic cardiomyopathy(https://www.kegg.jp/pathway/map=map05415&keyword=TGFB1), Cellular senescence(https://www.kegg.jp/pathway/map=map04218&keyword=TGFB1), Th17 cell differentiation(https://www.kegg.jp/pathway/map=map04659&keyword=TGFB1), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=TGFB1), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=TGFB1), Renal cell carcinoma(https://www.kegg.jp/pathway/map=map05211&keyword=TGFB1), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=TGFB1), MAPK signaling pathway(https://www.kegg.jp/pathway/map=map04010&keyword=TGFB1), FoxO signaling pathway(https://www.kegg.jp/pathway/map=map04068&keyword=TGFB1), Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=TGFB1), TGF-beta signaling pathway(https://www.kegg.jp/pathway/map=map04350&keyword=TGFB1), Osteoclast differentiation(https://www.kegg.jp/pathway/map=map04380&keyword=TGFB1), Hippo signaling pathway(https://www.kegg.jp/pathway/map=map04390&keyword=TGFB1), Relaxin signaling pathway(https://www.kegg.jp/pathway/map=map04926&keyword=TGFB1), Non-alcoholic fatty liver disease(https://www.kegg.jp/pathway/map=map04932&keyword=TGFB1), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=TGFB1), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=TGFB1), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=TGFB1)]','04010 MAPK signaling pathway; 04350 TGF-beta signaling pathway; 04390 Hippo signaling pathway; 04068 FoxO signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04110 Cell cycle; 04218 Cellular senescence; 04659 Th17 cell differentiation; 04672 Intestinal immune network for IgA production; 04926 Relaxin signaling pathway; 04380 Osteoclast differentiation; 05200 Pathways in cancer; 05205 Proteoglycans in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05220 Chronic myeloid leukemia; 05211 Renal cell carcinoma; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05410 Hypertrophic cardiomyopathy; 05414 Dilated cardiomyopathy; 05415 Diabetic cardiomyopathy; 04932 Non-alcoholic fatty liver disease; 04933 AGE-RAGE signaling pathway in diabetic complications; 03110 Chaperones and folding catalysts [BR:hsa03110]; 04052 Cytokines and growth factors [BR:hsa04052]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Others; Transforming growth factors (RSTK binding); Growth factors/receptors; '),(153,'Tjp1','[Tight junction(https://www.kegg.jp/pathway/map=map04530&keyword=Tjp1), Adherens junction(https://www.kegg.jp/pathway/map=map04520&keyword=Tjp1), Gap junction(https://www.kegg.jp/pathway/map=map04540&keyword=Tjp1), Vibrio cholerae infection(https://www.kegg.jp/pathway/map=map05110&keyword=Tjp1), Epithelial cell signaling in Helicobacter pylori infection(https://www.kegg.jp/pathway/map=map05120&keyword=Tjp1), Pathogenic Escherichia coli infection(https://www.kegg.jp/pathway/map=map05130&keyword=Tjp1)]','04520 Adherens junction; 04530 Tight junction; 04540 Gap junction; 04812 Cytoskeleton proteins [BR:mmu04812]; Others; '),(154,'Tlr2','[Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=Tlr2), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=Tlr2), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=Tlr2), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=Tlr2), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=Tlr2), Phagosome(https://www.kegg.jp/pathway/map=map04145&keyword=Tlr2), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=Tlr2), Neutrophil extracellular trap formation(https://www.kegg.jp/pathway/map=map04613&keyword=Tlr2), Salmonella infection(https://www.kegg.jp/pathway/map=map05132&keyword=Tlr2), Legionellosis(https://www.kegg.jp/pathway/map=map05134&keyword=Tlr2), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=Tlr2), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=Tlr2), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=Tlr2), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=Tlr2), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=Tlr2), Measles(https://www.kegg.jp/pathway/map=map05162&keyword=Tlr2), Herpes simplex virus 1 infection(https://www.kegg.jp/pathway/map=map05168&keyword=Tlr2), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=Tlr2), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=Tlr2), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=Tlr2)]','04151 PI3K-Akt signaling pathway; 04145 Phagosome; 04613 Neutrophil extracellular trap formation; 04620 Toll-like receptor signaling pathway; 05205 Proteoglycans in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05171 Coronavirus disease - COVID-19; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05169 Epstein-Barr virus infection; 05132 Salmonella infection; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05417 Lipid and atherosclerosis; 04131 Membrane trafficking [BR:mmu04131]; 04147 Exosome [BR:mmu04147]; 04054 Pattern recognition receptors [BR:mmu04054]; 04090 CD molecules [BR:mmu04090]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Toll-like receptors; Exosomal proteins of breast milk; Toll-like receptors; Proteins; Cell surface receptors; '),(155,'TLR2','[Inflammatory bowel disease(https://www.kegg.jp/pathway/map=map05321&keyword=TLR2), Toll-like receptor signaling pathway(https://www.kegg.jp/pathway/map=map04620&keyword=TLR2), Amoebiasis(https://www.kegg.jp/pathway/map=map05146&keyword=TLR2), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=TLR2), Tuberculosis(https://www.kegg.jp/pathway/map=map05152&keyword=TLR2), Phagosome(https://www.kegg.jp/pathway/map=map04145&keyword=TLR2), PI3K-Akt signaling pathway(https://www.kegg.jp/pathway/map=map04151&keyword=TLR2), Neutrophil extracellular trap formation(https://www.kegg.jp/pathway/map=map04613&keyword=TLR2), Salmonella infection(https://www.kegg.jp/pathway/map=map05132&keyword=TLR2), Legionellosis(https://www.kegg.jp/pathway/map=map05134&keyword=TLR2), Leishmaniasis(https://www.kegg.jp/pathway/map=map05140&keyword=TLR2), Chagas disease(https://www.kegg.jp/pathway/map=map05142&keyword=TLR2), Malaria(https://www.kegg.jp/pathway/map=map05144&keyword=TLR2), Toxoplasmosis(https://www.kegg.jp/pathway/map=map05145&keyword=TLR2), Hepatitis B(https://www.kegg.jp/pathway/map=map05161&keyword=TLR2), Measles(https://www.kegg.jp/pathway/map=map05162&keyword=TLR2), Herpes simplex virus 1 infection(https://www.kegg.jp/pathway/map=map05168&keyword=TLR2), Epstein-Barr virus infection(https://www.kegg.jp/pathway/map=map05169&keyword=TLR2), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=TLR2), Coronavirus disease - COVID-19(https://www.kegg.jp/pathway/map=map05171&keyword=TLR2)]','04151 PI3K-Akt signaling pathway; 04145 Phagosome; 04613 Neutrophil extracellular trap formation; 04620 Toll-like receptor signaling pathway; 05205 Proteoglycans in cancer; 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05171 Coronavirus disease - COVID-19; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05169 Epstein-Barr virus infection; 05132 Salmonella infection; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05417 Lipid and atherosclerosis; 04131 Membrane trafficking [BR:hsa04131]; 04147 Exosome [BR:hsa04147]; 04054 Pattern recognition receptors [BR:hsa04054]; 04090 CD molecules [BR:hsa04090]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Toll-like receptors; Exosomal proteins of breast milk; Toll-like receptors; Proteins; Cell surface receptors; '),(156,'Tnf','[<font color=\"red\">TNF</font> signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=Tnf), Apoptosis(https://www.kegg.jp/pathway/map=map04210&keyword=Tnf), Adipocytokine signaling pathway(https://www.kegg.jp/pathway/map=map04920&keyword=Tnf), NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=Tnf), Non-alcoholic fatty liver disease(https://www.kegg.jp/pathway/map=map04932&keyword=Tnf), Necroptosis(https://www.kegg.jp/pathway/map=map04217&keyword=Tnf), Graft-versus-host disease(https://www.kegg.jp/pathway/map=map05332&keyword=Tnf), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=Tnf), Type I diabetes mellitus(https://www.kegg.jp/pathway/map=map04940&keyword=Tnf), Insulin resistance(https://www.kegg.jp/pathway/map=map04931&keyword=Tnf), African trypanosomiasis(https://www.kegg.jp/pathway/map=map05143&keyword=Tnf), Antifolate resistance(https://www.kegg.jp/pathway/map=map01523&keyword=Tnf), Fc epsilon RI signaling pathway(https://www.kegg.jp/pathway/map=map04664&keyword=Tnf), Type II diabetes mellitus(https://www.kegg.jp/pathway/map=map04930&keyword=Tnf), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=Tnf), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=Tnf), Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=Tnf), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=Tnf), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=Tnf), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=Tnf)]','04010 MAPK signaling pathway; 04350 TGF-beta signaling pathway; 04064 NF-kappa B signaling pathway; 04668 TNF signaling pathway; 04071 Sphingolipid signaling pathway; 04150 mTOR signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04210 Apoptosis; 04217 Necroptosis; 04640 Hematopoietic cell lineage; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04650 Natural killer cell mediated cytotoxicity; 04612 Antigen processing and presentation; 04660 T cell receptor signaling pathway; 04657 IL-17 signaling pathway; 04664 Fc epsilon RI signaling pathway; 04920 Adipocytokine signaling pathway; 04380 Osteoclast differentiation; 05205 Proteoglycans in cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05132 Salmonella infection; 05135 Yersinia infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05310 Asthma; 05322 Systemic lupus erythematosus; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 05332 Graft-versus-host disease; 05010 Alzheimer disease; 05014 Amyotrophic lateral sclerosis; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 05410 Hypertrophic cardiomyopathy; 05414 Dilated cardiomyopathy; 04930 Type II diabetes mellitus; 04940 Type I diabetes mellitus; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 04933 AGE-RAGE signaling pathway in diabetic complications; 01523 Antifolate resistance; 04052 Cytokines and growth factors [BR:mmu04052]; 00536 Glycosaminoglycan binding proteins [BR:mmu00536]; Tumor necrosis fators; Cytokines; '),(157,'TNF','[<font color=\"red\">TNF</font> signaling pathway(https://www.kegg.jp/pathway/map=map04668&keyword=TNF), Apoptosis(https://www.kegg.jp/pathway/map=map04210&keyword=TNF), Adipocytokine signaling pathway(https://www.kegg.jp/pathway/map=map04920&keyword=TNF), NF-kappa B signaling pathway(https://www.kegg.jp/pathway/map=map04064&keyword=TNF), Non-alcoholic fatty liver disease(https://www.kegg.jp/pathway/map=map04932&keyword=TNF), Necroptosis(https://www.kegg.jp/pathway/map=map04217&keyword=TNF), Graft-versus-host disease(https://www.kegg.jp/pathway/map=map05332&keyword=TNF), Alcoholic liver disease(https://www.kegg.jp/pathway/map=map04936&keyword=TNF), Type I diabetes mellitus(https://www.kegg.jp/pathway/map=map04940&keyword=TNF), Insulin resistance(https://www.kegg.jp/pathway/map=map04931&keyword=TNF), African trypanosomiasis(https://www.kegg.jp/pathway/map=map05143&keyword=TNF), Antifolate resistance(https://www.kegg.jp/pathway/map=map01523&keyword=TNF), Fc epsilon RI signaling pathway(https://www.kegg.jp/pathway/map=map04664&keyword=TNF), Type II diabetes mellitus(https://www.kegg.jp/pathway/map=map04930&keyword=TNF), AGE-RAGE signaling pathway in diabetic complications(https://www.kegg.jp/pathway/map=map04933&keyword=TNF), Cytokine-cytokine receptor interaction(https://www.kegg.jp/pathway/map=map04060&keyword=TNF), Viral protein interaction with cytokine and cytokine receptor(https://www.kegg.jp/pathway/map=map04061&keyword=TNF), Intestinal immune network for IgA production(https://www.kegg.jp/pathway/map=map04672&keyword=TNF), Human immunodeficiency virus 1 infection(https://www.kegg.jp/pathway/map=map05170&keyword=TNF), Lipid and atherosclerosis(https://www.kegg.jp/pathway/map=map05417&keyword=TNF)]','04010 MAPK signaling pathway; 04350 TGF-beta signaling pathway; 04064 NF-kappa B signaling pathway; 04668 TNF signaling pathway; 04071 Sphingolipid signaling pathway; 04150 mTOR signaling pathway; 04060 Cytokine-cytokine receptor interaction; 04061 Viral protein interaction with cytokine and cytokine receptor; 04210 Apoptosis; 04217 Necroptosis; 04640 Hematopoietic cell lineage; 04620 Toll-like receptor signaling pathway; 04621 NOD-like receptor signaling pathway; 04622 RIG-I-like receptor signaling pathway; 04625 C-type lectin receptor signaling pathway; 04650 Natural killer cell mediated cytotoxicity; 04612 Antigen processing and presentation; 04660 T cell receptor signaling pathway; 04657 IL-17 signaling pathway; 04664 Fc epsilon RI signaling pathway; 04920 Adipocytokine signaling pathway; 04380 Osteoclast differentiation; 05205 Proteoglycans in cancer; 05166 Human T-cell leukemia virus 1 infection; 05170 Human immunodeficiency virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05171 Coronavirus disease - COVID-19; 05164 Influenza A; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05130 Pathogenic Escherichia coli infection; 05132 Salmonella infection; 05131 Shigellosis; 05135 Yersinia infection; 05133 Pertussis; 05134 Legionellosis; 05152 Tuberculosis; 05146 Amoebiasis; 05144 Malaria; 05145 Toxoplasmosis; 05140 Leishmaniasis; 05142 Chagas disease; 05143 African trypanosomiasis; 05310 Asthma; 05322 Systemic lupus erythematosus; 05323 Rheumatoid arthritis; 05321 Inflammatory bowel disease; 05330 Allograft rejection; 05332 Graft-versus-host disease; 05010 Alzheimer disease; 05014 Amyotrophic lateral sclerosis; 05020 Prion disease; 05022 Pathways of neurodegeneration - multiple diseases; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 05410 Hypertrophic cardiomyopathy; 05414 Dilated cardiomyopathy; 04930 Type II diabetes mellitus; 04940 Type I diabetes mellitus; 04936 Alcoholic liver disease; 04932 Non-alcoholic fatty liver disease; 04931 Insulin resistance; 04933 AGE-RAGE signaling pathway in diabetic complications; 01523 Antifolate resistance; 04052 Cytokines and growth factors [BR:hsa04052]; 00536 Glycosaminoglycan binding proteins [BR:hsa00536]; Tumor necrosis fators; Cytokines; '),(158,'Tob1','[]','03018 RNA degradation; 03019 Messenger RNA biogenesis [BR:mmu03019]; P-body specific factors; Other 3\'-5\' decay factors; '),(159,'Trp53','[]','04010 MAPK signaling pathway; 04310 Wnt signaling pathway; 04071 Sphingolipid signaling pathway; 04151 PI3K-Akt signaling pathway; 04137 Mitophagy - animal; 04110 Cell cycle; 04210 Apoptosis; 04216 Ferroptosis; 04115 p53 signaling pathway; 04218 Cellular senescence; 04919 Thyroid hormone signaling pathway; 04722 Neurotrophin signaling pathway; 04211 Longevity regulating pathway; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05206 MicroRNAs in cancer; 05205 Proteoglycans in cancer; 05203 Viral carcinogenesis; 05230 Central carbon metabolism in cancer; 05210 Colorectal cancer; 05212 Pancreatic cancer; 05225 Hepatocellular carcinoma; 05226 Gastric cancer; 05214 Glioma; 05216 Thyroid cancer; 05220 Chronic myeloid leukemia; 05217 Basal cell carcinoma; 05218 Melanoma; 05219 Bladder cancer; 05215 Prostate cancer; 05213 Endometrial cancer; 05224 Breast cancer; 05222 Small cell lung cancer; 05223 Non-small cell lung cancer; 05166 Human T-cell leukemia virus 1 infection; 05161 Hepatitis B; 05160 Hepatitis C; 05162 Measles; 05168 Herpes simplex virus 1 infection; 05163 Human cytomegalovirus infection; 05167 Kaposi sarcoma-associated herpesvirus infection; 05169 Epstein-Barr virus infection; 05165 Human papillomavirus infection; 05012 Parkinson disease; 05014 Amyotrophic lateral sclerosis; 05016 Huntington disease; 05417 Lipid and atherosclerosis; 05418 Fluid shear stress and atherosclerosis; 01524 Platinum drug resistance; 01522 Endocrine resistance; 03000 Transcription factors [BR:mmu03000]; 03036 Chromosome and associated proteins [BR:mmu03036]; 03400 DNA repair and recombination proteins [BR:mmu03400]; p53; Regulators of Aurora kinases; Other check point factors; '),(160,'Trp63','[]','05206 MicroRNAs in cancer; 03000 Transcription factors [BR:mmu03000]; p53; '),(161,'Trp73','[]','04390 Hippo signaling pathway; 04115 p53 signaling pathway; 04722 Neurotrophin signaling pathway; 05162 Measles; 03000 Transcription factors [BR:mmu03000]; p53; '),(162,'Vhl','[Renal cell carcinoma(https://www.kegg.jp/pathway/map=map05211&keyword=Vhl), HIF-1 signaling pathway(https://www.kegg.jp/pathway/map=map04066&keyword=Vhl), Ubiquitin mediated proteolysis(https://www.kegg.jp/pathway/map=map04120&keyword=Vhl), Longevity regulating pathway - worm(https://www.kegg.jp/pathway/map=map04212&keyword=Vhl), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Vhl)]','04120 Ubiquitin mediated proteolysis; 04066 HIF-1 signaling pathway; 05200 Pathways in cancer; 05211 Renal cell carcinoma; 04121 Ubiquitin system [BR:mmu04121]; Target recognizing subunit; '),(163,'Yy1','[]','03000 Transcription factors [BR:mmu03000]; 03036 Chromosome and associated proteins [BR:mmu03036]; 03029 Mitochondrial biogenesis [BR:mmu03029]; Cys2His2 others; Other polycomb group proteins; Ubiquitas transcription factors; '),(164,'Zbtb17','[Cell cycle(https://www.kegg.jp/pathway/map=map04110&keyword=Zbtb17), Pathways in cancer(https://www.kegg.jp/pathway/map=map05200&keyword=Zbtb17), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Zbtb17), Small cell lung cancer(https://www.kegg.jp/pathway/map=map05222&keyword=Zbtb17)]','04110 Cell cycle; 05200 Pathways in cancer; 05202 Transcriptional misregulation in cancer; 05222 Small cell lung cancer; 03000 Transcription factors [BR:mmu03000]; 04121 Ubiquitin system [BR:mmu04121]; Cys2His2 BTB-ZF factors; Adoptor and target recognizing subunit (BTB); '),(165,'Zeb1','[MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=Zeb1), Transcriptional misregulation in cancer(https://www.kegg.jp/pathway/map=map05202&keyword=Zeb1), Prostate cancer(https://www.kegg.jp/pathway/map=map05215&keyword=Zeb1)]','05202 Transcriptional misregulation in cancer; 05206 MicroRNAs in cancer; 05215 Prostate cancer; 03000 Transcription factors [BR:mmu03000]; Homeo domain ZF; '),(166,'Zeb2','[MicroRNAs in cancer(https://www.kegg.jp/pathway/map=map05206&keyword=Zeb2)]','05206 MicroRNAs in cancer; 03000 Transcription factors [BR:mmu03000]; Homeo domain ZF; ');
/*!40000 ALTER TABLE `gene_kegg_info` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `metabolism_hmdb_info`
--

DROP TABLE IF EXISTS `metabolism_hmdb_info`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `metabolism_hmdb_info` (
  `hmdb_info_index` int NOT NULL AUTO_INCREMENT,
  `metabolism_hmdb_info_index` varchar(45) DEFAULT NULL,
  `hmdb_pathway` varchar(45) DEFAULT NULL,
  `kegg_url` longtext,
  PRIMARY KEY (`hmdb_info_index`)
) ENGINE=InnoDB AUTO_INCREMENT=226 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `metabolism_hmdb_info`
--

LOCK TABLES `metabolism_hmdb_info` WRITE;
/*!40000 ALTER TABLE `metabolism_hmdb_info` DISABLE KEYS */;
INSERT INTO `metabolism_hmdb_info` VALUES (1,'HMDB0000012','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(2,'HMDB0000014','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(3,'HMDB0000016','Steroidogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00140.gif'),(4,'HMDB0000017','Vitamin B6 Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00750.gif'),(5,'HMDB0000022','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(6,'HMDB0000026','beta-Alanine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00410.gif'),(7,'HMDB0000026','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(8,'HMDB0000030','Biotin Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00780.gif'),(9,'HMDB0000030','Alanine, aspartate and glutamate metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(10,'HMDB0000034','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(11,'HMDB0000043','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(12,'HMDB0000043','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(13,'HMDB0000045','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(14,'HMDB0000045','Urea Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(15,'HMDB0000045','Histidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00340.gif'),(16,'HMDB0000050','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(17,'HMDB0000050','Selenocompound metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00450.gif'),(18,'HMDB0000054','Porphyrin Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00860.gif'),(19,'HMDB0000056','Propanoate metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00640.gif'),(20,'HMDB0000056','Aspartate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(21,'HMDB0000056','beta-Alanine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00410.gif'),(22,'HMDB0000056','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(23,'HMDB0000058','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(24,'HMDB0000063','Steroidogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00140.gif'),(25,'HMDB0000064','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(26,'HMDB0000064','Arginine and proline metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(27,'HMDB0000071','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(28,'HMDB0000079','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(29,'HMDB0000089','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(30,'HMDB0000094','Citric Acid Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00020.gif'),(31,'HMDB0000095','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(32,'HMDB0000095','Phosphatidylinositol Phosphate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00562.gif'),(33,'HMDB0000095','Pantothenate and CoA Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00770.gif'),(34,'HMDB0000097','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(35,'HMDB0000097','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(36,'HMDB0000097','Phospholipid Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00564.gif'),(37,'HMDB0000112','Glutamate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(38,'HMDB0000118','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(39,'HMDB0000123','Nitrogen metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00910.gif'),(40,'HMDB0000123','Primary bile acid biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00120.gif'),(41,'HMDB0000123','Porphyrin Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00860.gif'),(42,'HMDB0000123','Glutathione metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00480.gif'),(43,'HMDB0000123','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(44,'HMDB0000128','Arginine and proline metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(45,'HMDB0000128','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(46,'HMDB0000132','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(47,'HMDB0000148','Alanine, aspartate and glutamate metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(48,'HMDB0000148','Histidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00340.gif'),(49,'HMDB0000148','Nitrogen metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00910.gif'),(50,'HMDB0000148','Cysteine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(51,'HMDB0000151','Androgen and Estrogen Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00150.gif'),(52,'HMDB0000157','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(53,'HMDB0000158','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(54,'HMDB0000158','Phenylalanine and Tyrosine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00360.gif'),(55,'HMDB0000159','Phenylalanine and Tyrosine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00360.gif'),(56,'HMDB0000162','Arginine and proline metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(57,'HMDB0000172','Valine, leucine and isoleucine degradation','https://www.genome.jp/kegg/misc/thumbnail/map00280.gif'),(58,'HMDB0000175','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(59,'HMDB0000175','Aspartate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(60,'HMDB0000181','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(61,'HMDB0000187','Nitrogen metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00910.gif'),(62,'HMDB0000187','Starch and sucrose metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00500.gif'),(63,'HMDB0000187','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(64,'HMDB0000187','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(65,'HMDB0000195','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(66,'HMDB0000197','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(67,'HMDB0000205','Phenylalanine and Tyrosine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00360.gif'),(68,'HMDB0000208','Citric Acid Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00020.gif'),(69,'HMDB0000208','Gluconeogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00010.gif'),(70,'HMDB0000208','Glutamate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(71,'HMDB0000208','Urea Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(72,'HMDB0000210','beta-Alanine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00410.gif'),(73,'HMDB0000210','Pantothenate and CoA Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00770.gif'),(74,'HMDB0000220','Glycerolipid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00561.gif'),(75,'HMDB0000220','Fatty acid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00071.gif'),(76,'HMDB0000220','Fatty Acid Elongation In Mitochondria','https://www.genome.jp/kegg/misc/thumbnail/map00062.gif'),(77,'HMDB0000228','Sulfur metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00920.gif'),(78,'HMDB0000230','Amino Sugar Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00520.gif'),(79,'HMDB0000232','Nicotinate and nicotinamide metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00760.gif'),(80,'HMDB0000232','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(81,'HMDB0000234','Androgen and Estrogen Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00150.gif'),(82,'HMDB0000239','Vitamin B6 Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00750.gif'),(83,'HMDB0000241','Porphyrin Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00860.gif'),(84,'HMDB0000248','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(85,'HMDB0000258','Starch and Sucrose Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00500.gif'),(86,'HMDB0000258','Galactose Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00052.gif'),(87,'HMDB0000262','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(88,'HMDB0000267','Glutathione metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00480.gif'),(89,'HMDB0000269','Starch and sucrose metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00500.gif'),(90,'HMDB0000272','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(91,'HMDB0000273','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(92,'HMDB0000277','Starch and sucrose metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00500.gif'),(93,'HMDB0000289','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(94,'HMDB0000292','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(95,'HMDB0000296','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(96,'HMDB0000299','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(97,'HMDB0000300','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(98,'HMDB0000300','beta-Alanine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00410.gif'),(99,'HMDB0000305','Retinol Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00830.gif'),(100,'HMDB0000479','beta-Alanine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00410.gif'),(101,'HMDB0000479','Histidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00340.gif'),(102,'HMDB0000500','Ubiquinone Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00130.gif'),(103,'HMDB0000517','Urea Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(104,'HMDB0000517','Arginine and proline metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(105,'HMDB0000517','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(106,'HMDB0000518','Primary bile acid biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00120.gif'),(107,'HMDB0000574','Glutathione metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00480.gif'),(108,'HMDB0000574','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(109,'HMDB0000574','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(110,'HMDB0000574','Taurine and Hypotaurine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00430.gif'),(111,'HMDB0000574','Cysteine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(112,'HMDB0000619','Primary bile acid biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00120.gif'),(113,'HMDB0000626','Primary bile acid biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00120.gif'),(114,'HMDB0000638','Biosynthesis of unsaturated fatty acids','https://www.genome.jp/kegg/misc/thumbnail/map01040.gif'),(115,'HMDB0000641','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(116,'HMDB0000641','Glutamate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(117,'HMDB0000641','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(118,'HMDB0000641','Urea Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(119,'HMDB0000660','Starch and Sucrose Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00500.gif'),(120,'HMDB0000660','Galactose Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00052.gif'),(121,'HMDB0000660','Fructose and mannose metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00051.gif'),(122,'HMDB0000660','Amino Sugar Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00520.gif'),(123,'HMDB0000673','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(124,'HMDB0000684','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(125,'HMDB0000687','Valine, leucine and isoleucine degradation','https://www.genome.jp/kegg/misc/thumbnail/map00280.gif'),(126,'HMDB0000696','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(127,'HMDB0000696','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(128,'HMDB0000698','Primary bile acid biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00120.gif'),(129,'HMDB0000715','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(130,'HMDB0000716','Lysine degradation','https://www.genome.jp/kegg/misc/thumbnail/map00310.gif'),(131,'HMDB0000742','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(132,'HMDB0000742','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(133,'HMDB0000742','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(134,'HMDB0000763','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(135,'HMDB0000812','Aspartate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(136,'HMDB0000883','Valine, leucine and isoleucine degradation','https://www.genome.jp/kegg/misc/thumbnail/map00280.gif'),(137,'HMDB0000883','Propanoate metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00640.gif'),(138,'HMDB0000895','Phospholipid Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00564.gif'),(139,'HMDB0000903','Steroidogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00140.gif'),(140,'HMDB0000904','Arginine and proline metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(141,'HMDB0000904','Aspartate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(142,'HMDB0000904','Urea Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(143,'HMDB0000929','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(144,'HMDB0000939','Glycine, serine and threonine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00260.gif'),(145,'HMDB0000939','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(146,'HMDB0000939','Arginine and proline metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00330.gif'),(147,'HMDB0000949','Steroidogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00140.gif'),(148,'HMDB0000951','Primary bile acid biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00120.gif'),(149,'HMDB0000962','Valine, leucine and isoleucine degradation','https://www.genome.jp/kegg/misc/thumbnail/map00280.gif'),(150,'HMDB0000962','Citric Acid Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00020.gif'),(151,'HMDB0000973','Alanine, aspartate and glutamate metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(152,'HMDB0000973','Aspartate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(153,'HMDB0000978','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(154,'HMDB0001016','Pantothenate and CoA Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00770.gif'),(155,'HMDB0001023','Steroid Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00100.gif'),(156,'HMDB0001043','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(157,'HMDB0001043','Arachidonic Acid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00590.gif'),(158,'HMDB0001085','Arachidonic Acid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00590.gif'),(159,'HMDB0001132','Nicotinate and nicotinamide metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00760.gif'),(160,'HMDB0001173','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(161,'HMDB0001190','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(162,'HMDB0001200','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(163,'HMDB0001235','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(164,'HMDB0001257','Methionine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00270.gif'),(165,'HMDB0001264','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(166,'HMDB0001268','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(167,'HMDB0001268','Phenylalanine and Tyrosine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00360.gif'),(168,'HMDB0001285','Steroid Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00100.gif'),(169,'HMDB0001336','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(170,'HMDB0001347','Steroid Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00100.gif'),(171,'HMDB0001383','Starch and sucrose metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00500.gif'),(172,'HMDB0001388','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(173,'HMDB0001389','Tryptophan metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00380.gif'),(174,'HMDB0001397','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(175,'HMDB0001397','Glutamate Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(176,'HMDB0001398','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(177,'HMDB0001406','Nicotinate and nicotinamide metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00760.gif'),(178,'HMDB0001409','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(179,'HMDB0001431','Vitamin B6 Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00750.gif'),(180,'HMDB0001448','Sulfur metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00920.gif'),(181,'HMDB0001448','Starch and sucrose metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00500.gif'),(182,'HMDB0001488','Nicotinate and nicotinamide metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00760.gif'),(183,'HMDB0001490','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(184,'HMDB0001491','Vitamin B6 Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00750.gif'),(185,'HMDB0001491','Alanine, aspartate and glutamate metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00250.gif'),(186,'HMDB0001545','Vitamin B6 Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00750.gif'),(187,'HMDB0001545','Valine, leucine and isoleucine degradation','https://www.genome.jp/kegg/misc/thumbnail/map00280.gif'),(188,'HMDB0001547','Steroidogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00140.gif'),(189,'HMDB0001830','Steroidogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00140.gif'),(190,'HMDB0001847','Caffeine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00232.gif'),(191,'HMDB0001852','Retinol Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00830.gif'),(192,'HMDB0001999','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(193,'HMDB0002022','Purine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00230.gif'),(194,'HMDB0002183','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(195,'HMDB0002226','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(196,'HMDB0002311','Arachidonic Acid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00590.gif'),(197,'HMDB0002434','Riboflavin Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00740.gif'),(198,'HMDB0002434','Glycerolipid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00561.gif'),(199,'HMDB0002802','Steroidogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00140.gif'),(200,'HMDB0002961','Androgen and Estrogen Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00150.gif'),(201,'HMDB0003073','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(202,'HMDB0003374','D-Arginine and D-Ornithine Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00472.gif'),(203,'HMDB0003540','Pyrimidine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00240.gif'),(204,'HMDB0003701','Riboflavin Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00740.gif'),(205,'HMDB0003876','Arachidonic Acid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00590.gif'),(206,'HMDB0004058','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(207,'HMDB0004063','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(208,'HMDB0005079','Arachidonic Acid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00590.gif'),(209,'HMDB0006218','Retinol Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00830.gif'),(210,'HMDB0006224','Androgen and Estrogen Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00150.gif'),(211,'HMDB0006248','Glutathione metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00480.gif'),(212,'HMDB0006285','Retinol Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00830.gif'),(213,'HMDB0006344','Phenylalanine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00360.gif'),(214,'HMDB0006528','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(215,'HMDB0006762','Steroidogenesis','https://www.genome.jp/kegg/misc/thumbnail/map00140.gif'),(216,'HMDB0007853','Phospholipid Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00564.gif'),(217,'HMDB0007853','Glycerolipid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00561.gif'),(218,'HMDB0008204','alpha-Linolenic acid metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00592.gif'),(219,'HMDB0009778','Phospholipid Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00564.gif'),(220,'HMDB0010379','Arachidonic Acid Metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00590.gif'),(221,'HMDB0010382','Phospholipid Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00564.gif'),(222,'HMDB0012188','Ubiquinone Biosynthesis','https://www.genome.jp/kegg/misc/thumbnail/map00130.gif'),(223,'HMDB0037685','Tyrosine metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00350.gif'),(224,'HMDB0059661','Citric Acid Cycle','https://www.genome.jp/kegg/misc/thumbnail/map00020.gif'),(225,'HMDB0062559','Starch and sucrose metabolism','https://www.genome.jp/kegg/misc/thumbnail/map00500.gif');
/*!40000 ALTER TABLE `metabolism_hmdb_info` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2023-01-12 14:41:22
